Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
Charcot-Marie-Tooth disease type 1D ORPHA:101084	14/101	7.856467110538157E-15	3.598261936626476E-12	0	0	25.872722175497618	840.2797657021989	DUSP2;CD83;CXCL8;CCL22;TNFAIP3;FOS;TNF;STX11;ICAM1;NFKBIA;CXCL10;NR4A3;NFKBIZ;CCL4
Charcot-Marie-Tooth disease type 4E ORPHA:99951	14/101	7.856467110538157E-15	3.598261936626476E-12	0	0	25.872722175497618	840.2797657021989	DUSP2;CD83;CXCL8;CCL22;TNFAIP3;FOS;TNF;STX11;ICAM1;NFKBIA;CXCL10;NR4A3;NFKBIZ;CCL4
Nasopharyngeal carcinoma ORPHA:150	13/101	2.000442343352539E-13	6.108017288369751E-11	0	0	23.55892595307918	688.8685990922271	CXCL8;TNFAIP3;TNF;STX11;ICAM1;NFKBIA;IL1B;IRF1;CCL5;NFKBIZ;CCL4;LTB;BIRC3
Systemic-onset juvenile idiopathic arthritis ORPHA:85414	12/104	6.6146589102262495E-12	1.514756890441811E-9	0	0	20.630608695652175	531.0676182524505	NFKBIA;CXCL10;CXCL8;CCL20;IL1B;TNFAIP3;CCL2;CXCL1;TICAM1;CXCL3;CXCL2;ICAM1
Hereditary pediatric Behcet-like disease ORPHA:476102	11/101	9.758417269760736E-11	1.787742043820167E-8	0	0	19.18015873015873	442.108524035035	STAT5A;NFKBIA;CXCL8;IRF1;NFKBIZ;CCL4;TNFAIP3;TNF;STX11;ICAM1;BIRC3
Autosomal dominant hyper-IgE syndrome ORPHA:2314	9/101	3.121907446003804E-8	2.859667220539484E-6	0	0	15.11030910326087	261.13993653872126	STAT5A;NFKBIA;IRF1;NFKBIZ;TNFAIP2;TNFAIP3;STX11;ICAM1;BIRC3
NON RARE IN EUROPE: Psoriatic arthritis ORPHA:40050	9/101	3.121907446003804E-8	2.859667220539484E-6	0	0	15.11030910326087	261.13993653872126	NFKBIA;TNFSF14;IRF1;CCL5;CCL4;TNFAIP3;LTB;TNF;STX11
Chronic lymphoproliferative disorder of natural killer cells ORPHA:512017	9/101	3.121907446003804E-8	2.859667220539484E-6	0	0	15.11030910326087	261.13993653872126	STAT5A;NFKBIA;IRF1;NFKBIZ;TNFAIP2;TNFAIP3;STX11;ICAM1;BIRC3
STAT3-related early-onset multisystem autoimmune disease ORPHA:438159	9/101	3.121907446003804E-8	2.859667220539484E-6	0	0	15.11030910326087	261.13993653872126	STAT5A;NFKBIA;IRF1;NFKBIZ;TNFAIP2;TNFAIP3;STX11;ICAM1;BIRC3
T-cell large granular lymphocyte leukemia ORPHA:86872	9/101	3.121907446003804E-8	2.859667220539484E-6	0	0	15.11030910326087	261.13993653872126	STAT5A;NFKBIA;IRF1;NFKBIZ;TNFAIP2;TNFAIP3;STX11;ICAM1;BIRC3
Autosomal dominant dopa-responsive dystonia ORPHA:98808	8/101	4.6688423927190264E-7	3.28973817825433E-5	0	0	13.183295823955989	192.17533543380537	NFKBIA;IL23A;IRF1;CCL4;TNFAIP3;TNF;STX11;BIRC3
Quebec platelet disorder ORPHA:220436	8/101	4.6688423927190264E-7	3.28973817825433E-5	0	0	13.183295823955989	192.17533543380537	IL1A;SDC4;PLAU;LIF;C10ORF55;CXCL1;S100A3;CXCL3
GTP cyclohydrolase I deficiency ORPHA:2102	8/101	4.6688423927190264E-7	3.28973817825433E-5	0	0	13.183295823955989	192.17533543380537	NFKBIA;IL23A;IRF1;CCL4;TNFAIP3;TNF;STX11;BIRC3
Hypohidrotic ectodermal dysplasia with immunodeficiency ORPHA:98813	8/102	5.037221740945647E-7	3.295782224790152E-5	0	0	13.042388256638628	189.13081483913462	NFKBIA;IRF1;CCL4;TNFAIP3;LTB;TICAM1;TNF;STX11
Lattice corneal dystrophy type I ORPHA:98964	7/101	6.1057591574970855E-6	2.1324952544845717E-4	0	0	11.32430441898527	135.9627482341045	PLAU;TNFAIP2;CCL2;ADM;CXCL1;S100A3;THBS1
Reis-Bucklers corneal dystrophy ORPHA:98961	7/101	6.1057591574970855E-6	2.1324952544845717E-4	0	0	11.32430441898527	135.9627482341045	PLAU;TNFAIP2;CCL2;ADM;CXCL1;S100A3;THBS1
Cryptogenic multifocal ulcerous stenosing enteritis ORPHA:468635	7/101	6.1057591574970855E-6	2.1324952544845717E-4	0	0	11.32430441898527	135.9627482341045	CXCL8;IL1B;TNFAIP2;CYP1B1;CXCL1;CXCL3;CXCL2
Cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder ORPHA:477787	7/101	6.1057591574970855E-6	2.1324952544845717E-4	0	0	11.32430441898527	135.9627482341045	CXCL8;IL1B;TNFAIP2;CYP1B1;CXCL1;CXCL3;CXCL2
Epithelial basement membrane dystrophy ORPHA:98956	7/101	6.1057591574970855E-6	2.1324952544845717E-4	0	0	11.32430441898527	135.9627482341045	PLAU;TNFAIP2;CCL2;ADM;CXCL1;S100A3;THBS1
Thiel-Behnke corneal dystrophy ORPHA:98960	7/101	6.1057591574970855E-6	2.1324952544845717E-4	0	0	11.32430441898527	135.9627482341045	PLAU;TNFAIP2;CCL2;ADM;CXCL1;S100A3;THBS1
Granular corneal dystrophy type I ORPHA:98962	7/101	6.1057591574970855E-6	2.1324952544845717E-4	0	0	11.32430441898527	135.9627482341045	PLAU;TNFAIP2;CCL2;ADM;CXCL1;S100A3;THBS1
Granular corneal dystrophy type II ORPHA:98963	7/101	6.1057591574970855E-6	2.1324952544845717E-4	0	0	11.32430441898527	135.9627482341045	PLAU;TNFAIP2;CCL2;ADM;CXCL1;S100A3;THBS1
Metaphyseal anadysplasia ORPHA:1040	7/102	6.518544446022708E-6	2.1324952544845717E-4	0	0	11.204534412955466	133.7917706437393	CXCL10;CXCL8;IL1B;HSPA6;PTAFR;TNFAIP2;CXCL1
Niemann-Pick disease type C, adult neurologic onset ORPHA:216986	7/102	6.518544446022708E-6	2.1324952544845717E-4	0	0	11.204534412955466	133.7917706437393	IL1A;CXCL8;PLAU;ADM;CXCL1;CXCL3;ICAM1
Niemann-Pick disease type C, juvenile neurologic onset ORPHA:216981	7/102	6.518544446022708E-6	2.1324952544845717E-4	0	0	11.204534412955466	133.7917706437393	IL1A;CXCL8;PLAU;ADM;CXCL1;CXCL3;ICAM1
Niemann-Pick disease type C, late infantile neurologic onset ORPHA:216978	7/102	6.518544446022708E-6	2.1324952544845717E-4	0	0	11.204534412955466	133.7917706437393	IL1A;CXCL8;PLAU;ADM;CXCL1;CXCL3;ICAM1
Niemann-Pick disease type C, severe early infantile neurologic onset ORPHA:216975	7/102	6.518544446022708E-6	2.1324952544845717E-4	0	0	11.204534412955466	133.7917706437393	IL1A;CXCL8;PLAU;ADM;CXCL1;CXCL3;ICAM1
Niemann-Pick disease type C, severe perinatal form ORPHA:216972	7/102	6.518544446022708E-6	2.1324952544845717E-4	0	0	11.204534412955466	133.7917706437393	IL1A;CXCL8;PLAU;ADM;CXCL1;CXCL3;ICAM1
Pediatric systemic lupus erythematosus ORPHA:93552	7/103	6.954263695265993E-6	2.1965881189184996E-4	0	0	11.087259615384616	131.67402042708176	CXCL8;CSF1;IL1B;CCL4;TNFAIP3;TICAM1;ICAM1
Herpes simplex virus encephalitis ORPHA:1930	7/105	7.898515191167976E-6	2.4116799717032887E-4	0	0	10.85989010989011	127.59106534487073	NFKBIA;IRF1;TNFAIP3;TICAM1;STX11;ICAM1;BIRC3
Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial JAK1 deficiency ORPHA:574957	6/101	6.880916880675628E-5	0.0019696624570933984	0	0	9.53057452792286	91.34268034841577	IRF1;NFKBIZ;TNFAIP3;ETS1;STX11;BIRC3
Familial cavitary optic disc anomaly ORPHA:464760	6/101	6.880916880675628E-5	0.0019696624570933984	0	0	9.53057452792286	91.34268034841577	CSF1;PLAU;CCL2;CXCL3;CXCL2;THBS1
MALT lymphoma ORPHA:52417	6/104	8.101555250207631E-5	0.0022487953361182396	0	0	9.237420158903255	87.02452905335831	NFKBIA;IRF1;CCL5;NFKBIZ;TNFAIP3;BIRC3
NON RARE IN EUROPE: Crohn disease ORPHA:206	6/108	9.991052129997394E-5	0.0026917069856110627	0	0	8.873372249663223	81.73472199910931	TNFSF14;IRF1;CCL5;CCL4;LTB;TNF
Singleton-Merten dysplasia ORPHA:85191	5/100	6.266594552649808E-4	0.013347428785910305	0	0	7.881977671451356	58.130431050786996	CXCL10;IRF1;TNFAIP3;STX11;BIRC3
Immunodeficiency by defective expression of MHC class I ORPHA:34592	5/100	6.266594552649808E-4	0.013347428785910305	0	0	7.881977671451356	58.130431050786996	IRF1;TNFAIP3;LTB;STX11;BIRC3
Adenocarcinoma of ovary ORPHA:213504	5/101	6.557142962510522E-4	0.013347428785910305	0	0	7.799479166666667	57.16850842903147	IL1A;SDC4;PLAU;CCL2;THBS1
Birdshot chorioretinopathy ORPHA:179	5/101	6.557142962510522E-4	0.013347428785910305	0	0	7.799479166666667	57.16850842903147	IRF1;CCL4;TNFAIP3;LTB;STX11
Complement component 3 deficiency ORPHA:280133	5/101	6.557142962510522E-4	0.013347428785910305	0	0	7.799479166666667	57.16850842903147	SERPINA3;SDC4;CXCL2;CFB;CX3CL1
Complement hyperactivation-angiopathic thrombosis-protein-losing enteropathy syndrome ORPHA:566175	5/101	6.557142962510522E-4	0.013347428785910305	0	0	7.799479166666667	57.16850842903147	IRF1;NFKBIZ;TNFAIP3;STX11;BIRC3
Revesz syndrome ORPHA:3088	5/101	6.557142962510522E-4	0.013347428785910305	0	0	7.799479166666667	57.16850842903147	NFKBIA;CCL4;LTB;TNF;STX11
Generalized glucocorticoid resistance syndrome ORPHA:786	5/101	6.557142962510522E-4	0.013347428785910305	0	0	7.799479166666667	57.16850842903147	IRF1;TNFAIP3;ETS1;STX11;BIRC3
Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections-lymphopenia syndrome ORPHA:529977	5/101	6.557142962510522E-4	0.013347428785910305	0	0	7.799479166666667	57.16850842903147	IRF1;NFKBIZ;TNFAIP3;STX11;ICAM1
Infantile-onset pulmonary alveolar proteinosis-hypogammaglobulinemia ORPHA:572428	5/101	6.557142962510522E-4	0.013347428785910305	0	0	7.799479166666667	57.16850842903147	CXCL10;IRF1;CCL5;PTAFR;BIRC3
Interstitial lung disease-nephrotic syndrome-epidermolysis bullosa syndrome ORPHA:306504	5/101	6.557142962510522E-4	0.013347428785910305	0	0	7.799479166666667	57.16850842903147	SDC4;PLK2;LIF;S100A3;DKK1
Takayasu arteritis ORPHA:3287	5/103	7.168380374242216E-4	0.014274427006099719	0	0	7.6395330859616575	55.31526646321289	IRF1;CCL5;CCL4;TNF;STX11
Systemic lupus erythematosus ORPHA:536	5/128	0.0018909908371685347	0.03685420440098676	0	0	6.079083518107908	38.11983141451227	IRF1;CCL4;TNFAIP3;LTB;ETS1
Exfoliative ichthyosis ORPHA:289586	4/100	0.004973996484079867	0.05143454934318296	0	0	6.192669172932331	32.84301689755327	CXCL8;IL1B;PTAFR;STX11
AA amyloidosis ORPHA:85445	4/101	0.005152070525403527	0.05143454934318296	0	0	6.128517169211689	32.28721388482206	SERPINA3;SDC4;BDKRB2;CFB
LMNA-related cardiocutaneous progeria syndrome ORPHA:363618	4/101	0.005152070525403527	0.05143454934318296	0	0	6.128517169211689	32.28721388482206	SDC4;ID1;LIF;S100A3
MIRAGE syndrome ORPHA:494433	4/101	0.005152070525403527	0.05143454934318296	0	0	6.128517169211689	32.28721388482206	IRF1;TNFAIP3;STX11;BIRC3
Mandibuloacral dysplasia with type A lipodystrophy ORPHA:90153	4/101	0.005152070525403527	0.05143454934318296	0	0	6.128517169211689	32.28721388482206	SDC4;ID1;LIF;S100A3
Arnold-Chiari malformation type I ORPHA:268882	4/101	0.005152070525403527	0.05143454934318296	0	0	6.128517169211689	32.28721388482206	PLK2;ID1;S100A3;DKK1
Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency ORPHA:319595	4/101	0.005152070525403527	0.05143454934318296	0	0	6.128517169211689	32.28721388482206	CXCL10;IRF1;TNFAIP3;BIRC3
Atypical Werner syndrome ORPHA:79474	4/101	0.005152070525403527	0.05143454934318296	0	0	6.128517169211689	32.28721388482206	SDC4;ID1;LIF;S100A3
Autoimmune enteropathy and endocrinopathy-susceptibility to chronic infections syndrome ORPHA:391487	4/101	0.005152070525403527	0.05143454934318296	0	0	6.128517169211689	32.28721388482206	CXCL10;IRF1;TNFAIP3;BIRC3
Autosomal recessive Emery-Dreifuss muscular dystrophy ORPHA:98855	4/101	0.005152070525403527	0.05143454934318296	0	0	6.128517169211689	32.28721388482206	SDC4;ID1;LIF;S100A3
NIK deficiency ORPHA:447731	4/101	0.005152070525403527	0.05143454934318296	0	0	6.128517169211689	32.28721388482206	IRF1;LTB;TICAM1;BIRC3
NON RARE IN EUROPE: Ankylosing spondylitis ORPHA:825	4/101	0.005152070525403527	0.05143454934318296	0	0	6.128517169211689	32.28721388482206	IRF1;CCL4;LTB;STX11
Autosomal semi-dominant severe lipodystrophic laminopathy ORPHA:280365	4/101	0.005152070525403527	0.05143454934318296	0	0	6.128517169211689	32.28721388482206	SDC4;ID1;LIF;S100A3
Bacterial susceptibility due to TLR signaling pathway deficiency ORPHA:183713	4/101	0.005152070525403527	0.05143454934318296	0	0	6.128517169211689	32.28721388482206	IRF1;TNFAIP3;TNF;STX11
OBSOLETE: Alpha-1-antichymotrypsin deficiency ORPHA:93594	4/101	0.005152070525403527	0.05143454934318296	0	0	6.128517169211689	32.28721388482206	SERPINA3;SDC4;CFB;CX3CL1
Odonto-onycho-dermal dysplasia ORPHA:2721	4/101	0.005152070525403527	0.05143454934318296	0	0	6.128517169211689	32.28721388482206	DUSP2;LTB;TNF;BIRC3
Overgrowth-macrocephaly-facial dysmorphism syndrome ORPHA:137634	4/101	0.005152070525403527	0.05143454934318296	0	0	6.128517169211689	32.28721388482206	IRF1;PTAFR;TNFAIP2;STX11
Camurati-Engelmann disease ORPHA:1328	4/101	0.005152070525403527	0.05143454934318296	0	0	6.128517169211689	32.28721388482206	TOR4A;ITPRIP;TICAM1;STX11
Palmoplantar keratoderma, Nagashima type ORPHA:140966	4/101	0.005152070525403527	0.05143454934318296	0	0	6.128517169211689	32.28721388482206	IL1A;SDC4;PLAU;S100A3
Charcot-Marie-Tooth disease type 2B1 ORPHA:98856	4/101	0.005152070525403527	0.05143454934318296	0	0	6.128517169211689	32.28721388482206	SDC4;ID1;LIF;S100A3
Pulmonary arterial hypertension associated with connective tissue disease ORPHA:275798	4/101	0.005152070525403527	0.05143454934318296	0	0	6.128517169211689	32.28721388482206	IRF1;CCL4;LTB;STX11
Congenital muscular dystrophy due to LMNA mutation ORPHA:157973	4/101	0.005152070525403527	0.05143454934318296	0	0	6.128517169211689	32.28721388482206	SDC4;ID1;LIF;S100A3
Congenital plasminogen activator inhibitor type 1 deficiency ORPHA:465	4/101	0.005152070525403527	0.05143454934318296	0	0	6.128517169211689	32.28721388482206	PLAU;S100A3;DKK1;THBS1
STING-associated vasculopathy with onset in infancy ORPHA:425120	4/101	0.005152070525403527	0.05143454934318296	0	0	6.128517169211689	32.28721388482206	STAT5A;IRF1;TNFAIP3;STX11
Deficiency in anterior pituitary function-variable immunodeficiency syndrome ORPHA:293978	4/101	0.005152070525403527	0.05143454934318296	0	0	6.128517169211689	32.28721388482206	IL23A;TNFAIP3;TICAM1;ICAM1
Schopf-Schulz-Passarge syndrome ORPHA:50944	4/101	0.005152070525403527	0.05143454934318296	0	0	6.128517169211689	32.28721388482206	DUSP2;LTB;TNF;BIRC3
Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome ORPHA:2229	4/101	0.005152070525403527	0.05143454934318296	0	0	6.128517169211689	32.28721388482206	SDC4;ID1;LIF;S100A3
FTH1-related iron overload ORPHA:247790	4/101	0.005152070525403527	0.05143454934318296	0	0	6.128517169211689	32.28721388482206	CXCL8;CXCL1;TICAM1;CXCL3
Familial dilated cardiomyopathy with conduction defect due to LMNA mutation ORPHA:300751	4/101	0.005152070525403527	0.05143454934318296	0	0	6.128517169211689	32.28721388482206	SDC4;ID1;LIF;S100A3
Susceptibility to viral and mycobacterial infections due to STAT1 deficiency ORPHA:391311	4/101	0.005152070525403527	0.05143454934318296	0	0	6.128517169211689	32.28721388482206	CXCL10;IRF1;TNFAIP3;BIRC3
Familial normophosphatemic tumoral calcinosis ORPHA:306658	4/101	0.005152070525403527	0.05143454934318296	0	0	6.128517169211689	32.28721388482206	IRF1;TNFAIP3;STX11;BIRC3
Familial partial lipodystrophy, Dunnigan type ORPHA:2348	4/101	0.005152070525403527	0.05143454934318296	0	0	6.128517169211689	32.28721388482206	SDC4;ID1;LIF;S100A3
Familial partial lipodystrophy, Kobberling type ORPHA:79084	4/101	0.005152070525403527	0.05143454934318296	0	0	6.128517169211689	32.28721388482206	SDC4;ID1;LIF;S100A3
Thrombomodulin-related bleeding disorder ORPHA:436169	4/101	0.005152070525403527	0.05143454934318296	0	0	6.128517169211689	32.28721388482206	MAFB;IL1B;TNFAIP2;CXCL1
Tumor necrosis factor receptor 1 associated periodic syndrome ORPHA:32960	4/101	0.005152070525403527	0.05143454934318296	0	0	6.128517169211689	32.28721388482206	TOR4A;ITPRIP;TNFAIP2;ADM
Galactose mutarotase deficiency ORPHA:570422	4/101	0.005152070525403527	0.05143454934318296	0	0	6.128517169211689	32.28721388482206	TNFSF14;IRF1;CCL5;CCL4
Variant ABeta2M amyloidosis ORPHA:314652	4/101	0.005152070525403527	0.05143454934318296	0	0	6.128517169211689	32.28721388482206	IRF1;CCL5;STX11;BIRC3
Waldenstrom macroglobulinemia ORPHA:33226	4/101	0.005152070525403527	0.05143454934318296	0	0	6.128517169211689	32.28721388482206	IRF1;TNFAIP3;TNF;STX11
Griscelli syndrome type 2 ORPHA:79477	4/101	0.005152070525403527	0.05143454934318296	0	0	6.128517169211689	32.28721388482206	TNFSF14;IRF1;CCL5;STX11
Heart-hand syndrome, Slovenian type ORPHA:168796	4/101	0.005152070525403527	0.05143454934318296	0	0	6.128517169211689	32.28721388482206	SDC4;ID1;LIF;S100A3
Heme oxygenase-1 deficiency ORPHA:562509	4/101	0.005152070525403527	0.05143454934318296	0	0	6.128517169211689	32.28721388482206	TNFAIP2;ADM;CXCL1;ICAM1
Hyper-IgM syndrome type 3 ORPHA:101090	4/101	0.005152070525403527	0.05143454934318296	0	0	6.128517169211689	32.28721388482206	CXCL10;PTAFR;CCL4;BIRC3
Infantile inflammatory bowel disease with neurological involvement ORPHA:565788	4/101	0.005152070525403527	0.05143454934318296	0	0	6.128517169211689	32.28721388482206	TOR4A;ITPRIP;TICAM1;STX11
Juvenile Paget disease ORPHA:2801	4/102	0.005334369200439281	0.05143454934318296	0	0	6.065674390056775	31.745220314113233	SDC4;LIF;BDKRB2;CFB
Atypical hemolytic uremic syndrome with complement gene abnormality ORPHA:544472	4/102	0.005334369200439281	0.05143454934318296	0	0	6.065674390056775	31.745220314113233	SERPINA3;CXCL1;CXCL2;CFB
Familial primary localized cutaneous amyloidosis ORPHA:353220	4/102	0.005334369200439281	0.05143454934318296	0	0	6.065674390056775	31.745220314113233	PLAU;S100A3;DKK1;THBS1
Thyroid ectopia ORPHA:95712	4/102	0.005334369200439281	0.05143454934318296	0	0	6.065674390056775	31.745220314113233	PLAU;LIF;S100A3;DKK1
Vogt-Koyanagi-Harada disease ORPHA:3437	4/102	0.005334369200439281	0.05143454934318296	0	0	6.065674390056775	31.745220314113233	IRF1;TNFAIP3;STX11;BIRC3
Autoimmune lymphoproliferative syndrome ORPHA:3261	4/105	0.005907052556738403	0.05578206331930286	0	0	5.8846125214025164	30.197526417868914	IRF1;CCL5;CCL4;LTB
Diffuse cutaneous systemic sclerosis ORPHA:220393	4/105	0.005907052556738403	0.05578206331930286	0	0	5.8846125214025164	30.197526417868914	IRF1;PTAFR;CCL4;BIRC3
Congenital generalized lipodystrophy ORPHA:528	4/106	0.00610668711620904	0.056502276751994755	0	0	5.826625386996904	29.706297083369822	SDC4;ID1;S100A3;FOS
Hypoplastic amelogenesis imperfecta ORPHA:100031	4/106	0.00610668711620904	0.056502276751994755	0	0	5.826625386996904	29.706297083369822	CXCL8;PLAU;CXCL1;BIRC3
Primary biliary cholangitis ORPHA:186	4/108	0.006519321513916441	0.0597169850674746	0	0	5.713996529786003	28.75845865728024	IRF1;CCL5;PTAFR;LTB
Keratolytic winter erythema ORPHA:50943	3/101	0.03222354874196304	0.19275891911381163	0	0	4.51530612244898	15.510337363281113	CSF1;CCL2;CXCL1
Aceruloplasminemia ORPHA:48818	3/101	0.03222354874196304	0.19275891911381163	0	0	4.51530612244898	15.510337363281113	SERPINA3;CFB;CX3CL1
Acute encephalopathy with biphasic seizures and late reduced diffusion ORPHA:363549	3/101	0.03222354874196304	0.19275891911381163	0	0	4.51530612244898	15.510337363281113	CCL4;LTB;TNF
Aneurysm-osteoarthritis syndrome ORPHA:284984	3/101	0.03222354874196304	0.19275891911381163	0	0	4.51530612244898	15.510337363281113	LIF;DKK1;THBS1
Marfan syndrome type 2 ORPHA:284973	3/101	0.03222354874196304	0.19275891911381163	0	0	4.51530612244898	15.510337363281113	IRF1;NFKBIZ;ETS1
Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR1 deficiency ORPHA:99898	3/101	0.03222354874196304	0.19275891911381163	0	0	4.51530612244898	15.510337363281113	PTAFR;CCL4;STX11
Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR2 deficiency ORPHA:319547	3/101	0.03222354874196304	0.19275891911381163	0	0	4.51530612244898	15.510337363281113	IL1B;PTAFR;TNFAIP2
Mendelian susceptibility to mycobacterial diseases due to complete IL12B deficiency ORPHA:319558	3/101	0.03222354874196304	0.19275891911381163	0	0	4.51530612244898	15.510337363281113	CCL22;TNFSF14;TNF
Metaphyseal dysplasia-maxillary hypoplasia-brachydacty syndrome ORPHA:2504	3/101	0.03222354874196304	0.19275891911381163	0	0	4.51530612244898	15.510337363281113	IL1B;IRF1;STX11
Autoimmune lymphoproliferative syndrome with recurrent viral infections ORPHA:275517	3/101	0.03222354874196304	0.19275891911381163	0	0	4.51530612244898	15.510337363281113	IRF1;CCL5;BIRC3
Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency ORPHA:319581	3/101	0.03222354874196304	0.19275891911381163	0	0	4.51530612244898	15.510337363281113	PTAFR;CCL4;STX11
Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency ORPHA:319589	3/101	0.03222354874196304	0.19275891911381163	0	0	4.51530612244898	15.510337363281113	IL1B;PTAFR;TNFAIP2
Multiple paragangliomas associated with polycythemia ORPHA:324299	3/101	0.03222354874196304	0.19275891911381163	0	0	4.51530612244898	15.510337363281113	SDC4;BDKRB2;CFB
Autosomal recessive brachyolmia ORPHA:448242	3/101	0.03222354874196304	0.19275891911381163	0	0	4.51530612244898	15.510337363281113	SDC4;ADM;THBS1
Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency ORPHA:319569	3/101	0.03222354874196304	0.19275891911381163	0	0	4.51530612244898	15.510337363281113	PTAFR;CCL4;STX11
Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency ORPHA:319574	3/101	0.03222354874196304	0.19275891911381163	0	0	4.51530612244898	15.510337363281113	IL1B;PTAFR;TNFAIP2
NON RARE IN EUROPE: Wolff-Parkinson-White syndrome ORPHA:907	3/101	0.03222354874196304	0.19275891911381163	0	0	4.51530612244898	15.510337363281113	IL1B;CXCL1;STX11
B4GALT1-CDG ORPHA:79332	3/101	0.03222354874196304	0.19275891911381163	0	0	4.51530612244898	15.510337363281113	TOR4A;TNFAIP3;TICAM1
Benign recurrent intrahepatic cholestasis type 1 ORPHA:99960	3/101	0.03222354874196304	0.19275891911381163	0	0	4.51530612244898	15.510337363281113	BDKRB2;THBS1;CFB
Neutrophil immunodeficiency syndrome ORPHA:183707	3/101	0.03222354874196304	0.19275891911381163	0	0	4.51530612244898	15.510337363281113	IRF1;LTB;STX11
Blau syndrome ORPHA:90340	3/101	0.03222354874196304	0.19275891911381163	0	0	4.51530612244898	15.510337363281113	PTAFR;CCL4;TNF
Osteofibrous dysplasia ORPHA:488265	3/101	0.03222354874196304	0.19275891911381163	0	0	4.51530612244898	15.510337363281113	SDC4;ID1;DKK1
Palmoplantar keratoderma-esophageal carcinoma syndrome ORPHA:2198	3/101	0.03222354874196304	0.19275891911381163	0	0	4.51530612244898	15.510337363281113	IRF1;PTAFR;TICAM1
Papillon-Lefevre ORPHA:678	3/101	0.03222354874196304	0.19275891911381163	0	0	4.51530612244898	15.510337363281113	IL1B;PTAFR;ICAM1
Charcot-Marie-Tooth disease type 1C ORPHA:101083	3/101	0.03222354874196304	0.19275891911381163	0	0	4.51530612244898	15.510337363281113	IRF1;PTAFR;CCL4
Chondrosarcoma ORPHA:55880	3/101	0.03222354874196304	0.19275891911381163	0	0	4.51530612244898	15.510337363281113	PLK2;DKK1;THBS1
Cleidocranial dysplasia ORPHA:1452	3/101	0.03222354874196304	0.19275891911381163	0	0	4.51530612244898	15.510337363281113	IL1B;IRF1;STX11
Predisposition to severe viral infection due to IRF7 deficiency ORPHA:574918	3/101	0.03222354874196304	0.19275891911381163	0	0	4.51530612244898	15.510337363281113	IRF1;LTB;TNF
Combined immunodeficiency due to MALT1 deficiency ORPHA:397964	3/101	0.03222354874196304	0.19275891911381163	0	0	4.51530612244898	15.510337363281113	TNFAIP3;ETS1;BIRC3
Combined immunodeficiency due to Moesin deficiency ORPHA:504530	3/101	0.03222354874196304	0.19275891911381163	0	0	4.51530612244898	15.510337363281113	ITPRIP;ETS1;STX11
Combined immunodeficiency due to OX40 deficiency ORPHA:431149	3/101	0.03222354874196304	0.19275891911381163	0	0	4.51530612244898	15.510337363281113	CCL4;LTB;TNF
Proteasome-associated autoinflammatory syndrome ORPHA:324977	3/101	0.03222354874196304	0.19275891911381163	0	0	4.51530612244898	15.510337363281113	STAT5A;IRF1;BIRC3
Recessive X-linked ichthyosis ORPHA:461	3/101	0.03222354874196304	0.19275891911381163	0	0	4.51530612244898	15.510337363281113	RCAN1;BDKRB2;CFB
Spondyloepimetaphyseal dysplasia, PAPSS2 type ORPHA:93282	3/101	0.03222354874196304	0.19275891911381163	0	0	4.51530612244898	15.510337363281113	SDC4;ADM;THBS1
Sterile multifocal osteomyelitis with periostitis and pustulosis ORPHA:210115	3/101	0.03222354874196304	0.19275891911381163	0	0	4.51530612244898	15.510337363281113	IL1B;PTAFR;CCL4
Syndromic recessive X-linked ichthyosis ORPHA:281090	3/101	0.03222354874196304	0.19275891911381163	0	0	4.51530612244898	15.510337363281113	RCAN1;BDKRB2;CFB
T-B+ severe combined immunodeficiency due to IL-7Ralpha deficiency ORPHA:169154	3/101	0.03222354874196304	0.19275891911381163	0	0	4.51530612244898	15.510337363281113	IRF1;CCL5;ETS1
Fatal congenital hypertrophic cardiomyopathy due to glycogen storage disease ORPHA:439854	3/101	0.03222354874196304	0.19275891911381163	0	0	4.51530612244898	15.510337363281113	IL1B;CXCL1;STX11
GM2 gangliosidosis, AB variant ORPHA:309246	3/101	0.03222354874196304	0.19275891911381163	0	0	4.51530612244898	15.510337363281113	CCL22;PTAFR;ICAM1
Glycerol kinase deficiency, adult form ORPHA:284414	3/101	0.03222354874196304	0.19275891911381163	0	0	4.51530612244898	15.510337363281113	TNFSF14;PTAFR;CCL4
Glycerol kinase deficiency, juvenile form ORPHA:284411	3/101	0.03222354874196304	0.19275891911381163	0	0	4.51530612244898	15.510337363281113	TNFSF14;PTAFR;CCL4
Growth retardation-mild developmental delay-chronic hepatitis syndrome ORPHA:391366	3/101	0.03222354874196304	0.19275891911381163	0	0	4.51530612244898	15.510337363281113	ITPRIP;ETS1;STX11
Haim-Munk syndrome ORPHA:2342	3/101	0.03222354874196304	0.19275891911381163	0	0	4.51530612244898	15.510337363281113	IL1B;PTAFR;ICAM1
Hemochromatosis type 5 ORPHA:447792	3/101	0.03222354874196304	0.19275891911381163	0	0	4.51530612244898	15.510337363281113	ADM;THBS1;CXCL5
Hepatic veno-occlusive disease-immunodeficiency syndrome ORPHA:79124	3/101	0.03222354874196304	0.19275891911381163	0	0	4.51530612244898	15.510337363281113	IRF1;CCL5;BIRC3
Hereditary arterial and articular multiple calcification syndrome ORPHA:289601	3/101	0.03222354874196304	0.19275891911381163	0	0	4.51530612244898	15.510337363281113	S100A3;DKK1;THBS1
Hereditary papillary renal cell carcinoma ORPHA:47044	3/101	0.03222354874196304	0.19275891911381163	0	0	4.51530612244898	15.510337363281113	SDC4;ID1;DKK1
Immunodeficiency due to CD25 deficiency ORPHA:169100	3/101	0.03222354874196304	0.19275891911381163	0	0	4.51530612244898	15.510337363281113	CCL5;CCL4;LTB
Immunodeficiency with factor I anomaly ORPHA:200418	3/101	0.03222354874196304	0.19275891911381163	0	0	4.51530612244898	15.510337363281113	SERPINA3;CFB;CX3CL1
Loeys-Dietz syndrome ORPHA:60030	3/102	0.0330383736909044	0.19275891911381163	0	0	4.469470827679783	15.241277903365983	ITPRIP;NFKBIZ;ETS1
Musculocontractural Ehlers-Danlos syndrome ORPHA:2953	3/102	0.0330383736909044	0.19275891911381163	0	0	4.469470827679783	15.241277903365983	ITPRIP;PLAU;ADM
Autosomal recessive generalized dystrophic epidermolysis bullosa, severe form ORPHA:79408	3/102	0.0330383736909044	0.19275891911381163	0	0	4.469470827679783	15.241277903365983	PLAU;BDKRB2;S100A3
Cap myopathy ORPHA:171881	3/102	0.0330383736909044	0.19275891911381163	0	0	4.469470827679783	15.241277903365983	PLAU;S100A3;DKK1
Crisponi syndrome ORPHA:1545	3/102	0.0330383736909044	0.19275891911381163	0	0	4.469470827679783	15.241277903365983	LIF;S100A3;DKK1
Roussy-Levy syndrome ORPHA:3115	3/102	0.0330383736909044	0.19275891911381163	0	0	4.469470827679783	15.241277903365983	C11ORF96;CSF1;CCL2
Solitary fibrous tumor/hemangiopericytoma ORPHA:2126	3/102	0.0330383736909044	0.19275891911381163	0	0	4.469470827679783	15.241277903365983	TOR4A;TICAM1;ICAM1
Intermittent hydrarthrosis ORPHA:329967	3/102	0.0330383736909044	0.19275891911381163	0	0	4.469470827679783	15.241277903365983	IRF1;PTAFR;TNFAIP2
Auriculocondylar syndrome ORPHA:137888	3/103	0.03386389813000045	0.19387081679425258	0	0	4.42455223880597	14.978904740763591	PLK2;DKK1;THBS1
Familial Chilblain lupus ORPHA:481662	3/103	0.03386389813000045	0.19387081679425258	0	0	4.42455223880597	14.978904740763591	IRF1;CCL5;STX11
Familial hypercholanemia ORPHA:238475	3/103	0.03386389813000045	0.19387081679425258	0	0	4.42455223880597	14.978904740763591	SERPINA3;SDC4;CFB
Dejerine-Sottas syndrome ORPHA:64748	3/104	0.034700099897387086	0.19500178838040844	0	0	4.3805231269395595	14.722993919874943	C11ORF96;CSF1;CCL2
Familial hemophagocytic lymphohistiocytosis ORPHA:540	3/104	0.034700099897387086	0.19500178838040844	0	0	4.3805231269395595	14.722993919874943	IRF1;LTB;STX11
Giant cell arteritis ORPHA:397	3/104	0.034700099897387086	0.19500178838040844	0	0	4.3805231269395595	14.722993919874943	IRF1;CCL4;BIRC3
NON RARE IN EUROPE: Ulcerative colitis ORPHA:771	3/105	0.03554695555013182	0.19733946232679242	0	0	4.3373573309920985	14.473330995578062	IRF1;CCL5;CCL4
Chronic mucocutaneous candidiasis ORPHA:1334	3/105	0.03554695555013182	0.19733946232679242	0	0	4.3373573309920985	14.473330995578062	NFKBIA;IRF1;PTAFR
NON RARE IN EUROPE: Multiple sclerosis ORPHA:802	3/106	0.03640444042130974	0.19967944566418996	0	0	4.295029705839734	14.229710540140337	PTAFR;CCL4;LTB
NON RARE IN EUROPE: Primary adult open-angle glaucoma ORPHA:353225	3/106	0.03640444042130974	0.19967944566418996	0	0	4.295029705839734	14.229710540140337	SDC4;DNAJB4;CYP1B1
Aicardi-Goutieres syndrome ORPHA:51	3/107	0.03727252859538001	0.20322402496052433	0	0	4.25351607347876	13.991935689689381	IRF1;LTB;TNF
Behcet disease ORPHA:117	3/114	0.04364361668492182	0.23655356735732772	0	0	3.9838644614764016	12.476261346286444	IRF1;CCL5;CCL4
Periodontal Ehlers-Danlos syndrome ORPHA:75392	2/100	0.14995070808433184	0.4838060079820406	0	0	2.9879062736205593	5.669398730173793	SERPINA3;CFB
De novo thrombotic microangiopathy after kidney transplantation ORPHA:244275	2/100	0.14995070808433184	0.4838060079820406	0	0	2.9879062736205593	5.669398730173793	SERPINA3;CFB
Severe generalized junctional epidermolysis bullosa ORPHA:79404	2/100	0.14995070808433184	0.4838060079820406	0	0	2.9879062736205593	5.669398730173793	SDC4;BDKRB2
Hyperandrogenism due to cortisone reductase deficiency ORPHA:168588	2/100	0.14995070808433184	0.4838060079820406	0	0	2.9879062736205593	5.669398730173793	CSF1;CFB
Juvenile hyaline fibromatosis ORPHA:2028	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	IL1B;ETS1
Keratoderma hereditarium mutilans ORPHA:494	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	SDC4;CFB
Kindler epidermolysis bullosa ORPHA:2908	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	SDC4;ID1
Knuckle pads-leukonychia-sensorineural deafness-palmoplantar hyperkeratosis syndrome ORPHA:2698	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	SDC4;CFB
Kuru ORPHA:454745	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	RCAN1;DNAJB4
Laron syndrome with immunodeficiency ORPHA:220465	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	STAT5A;LTB
Laryngo-onycho-cutaneous syndrome ORPHA:2407	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	SDC4;BDKRB2
Lipoid proteinosis ORPHA:530	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	PLAU;S100A3
Acute myeloid leukemia with CEBPA somatic mutations ORPHA:319480	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	MAFB;PTAFR
Lipoprotein glomerulopathy ORPHA:329481	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	C11ORF96;CX3CL1
Acute neonatal citrullinemia type I ORPHA:247546	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	ID1;BDKRB2
Adult polyglucosan body disease ORPHA:206583	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	DNAJB4;S100A3
Adult-onset citrullinemia type I ORPHA:247573	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	ID1;BDKRB2
Alagille syndrome due to a NOTCH2 point mutation ORPHA:261629	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	CYP1B1;THBS1
Macular corneal dystrophy ORPHA:98969	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	HAP1;GPM6B
Male infertility due to large-headed multiflagellar polyploid spermatozoa ORPHA:137893	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	FKBPL;PLAU
Amyloidosis cutis dyschromia ORPHA:319635	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	CCL2;CFB
Ataxia-pancytopenia syndrome ORPHA:2585	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	IRF1;BIRC3
Atrial septal defect, sinus venosus type ORPHA:99105	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	ITPRIP;CITED2
Autosomal dominant Kenny-Caffey syndrome ORPHA:93325	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	IRF1;BIRC3
Monilethrix ORPHA:573	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	S100A3;DKK1
Monoamine oxidase A deficiency ORPHA:3057	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	SERPINA3;SDC4
Muscular dystrophy, Selcen type ORPHA:199340	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	SDC4;ID1
Autosomal recessive congenital cerebellar ataxia due to GRID2 deficiency ORPHA:363432	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	UNC13A;GPM6B
Autosomal recessive nail dysplasia ORPHA:280654	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	PLK2;DKK1
Nail-patella syndrome ORPHA:2614	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	NANOS1;HAP1
Nail-patella-like renal disease ORPHA:2613	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	NANOS1;HAP1
Neonatal acute respiratory distress due to SP-B deficiency ORPHA:217563	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	TNFSF14;CCL5
Beckwith-Wiedemann syndrome due to CDKN1C mutation ORPHA:231120	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	MAFB;TMEM88
Benign familial mesial temporal lobe epilepsy ORPHA:163717	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	SDC4;CXCL3
Beta-propeller protein-associated neurodegeneration ORPHA:329284	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	IRF1;DEDD2
Obesity due to pro-opiomelanocortin deficiency ORPHA:71526	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	CCL4;LTB
Osteocraniostenosis ORPHA:2763	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	IRF1;BIRC3
CLN11 disease ORPHA:314629	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	TOR4A;TICAM1
PPARG-related familial partial lipodystrophy ORPHA:79083	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	SDC4;CFB
Charcot-Marie-Tooth disease type 4D ORPHA:99950	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	MAFB;CFB
Charcot-Marie-Tooth disease type 4H ORPHA:99954	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	MAFB;SOD2
Clear cell renal carcinoma ORPHA:319276	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	PTAFR;TNFAIP2
Porokeratotic eccrine ostial and dermal duct nevus ORPHA:166286	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	SDC4;CFB
PrP systemic amyloidosis ORPHA:397606	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	RCAN1;DNAJB4
Primary CD59 deficiency ORPHA:169464	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	SDC4;S100A3
Combined immunodeficiency due to IL21R deficiency ORPHA:357329	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	TNFSF14;LTB
Primary lateral sclerosis ORPHA:35689	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	L3MBTL1;SPG7
Congenital bile acid synthesis defect type 1 ORPHA:79301	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	SDC4;CFB
Congenital muscular dystrophy-respiratory failure-skin abnormalities-joint hyperlaxity syndrome ORPHA:486815	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	IL23A;STX11
Congenital myopathy with internal nuclei and atypical cores ORPHA:319160	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	GAPDHS;FSCN2
Congenital nephrotic syndrome, Finnish type ORPHA:839	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	UNC13A;HAP1
Retinal macular dystrophy type 2 ORPHA:319640	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	FOXJ1;CX3CL1
Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations ORPHA:247691	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	TICAM1;STX11
Cystathioninuria ORPHA:212	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	CHAC1;INHBC
Sea-blue histiocytosis ORPHA:158029	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	C11ORF96;CX3CL1
Severe combined immunodeficiency due to LAT deficiency ORPHA:504523	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	CCL5;LTB
Dysbetalipoproteinemia ORPHA:412	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	C11ORF96;CX3CL1
Enamel-renal syndrome ORPHA:1031	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	SOD2;CFB
Spastic paraplegia type 7 ORPHA:99013	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	L3MBTL1;SPG7
Episodic ataxia type 6 ORPHA:209967	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	GPM6B;CAMK1G
Familial Alzheimer-like prion disease ORPHA:280397	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	RCAN1;DNAJB4
Spondyloenchondrodysplasia ORPHA:1855	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	STAT5A;CCL4
Sporadic fatal insomnia ORPHA:586130	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	RCAN1;DNAJB4
Familial drusen ORPHA:75376	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	SERPINA3;CFB
Familial mesial temporal lobe epilepsy with febrile seizures ORPHA:165805	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	SDC4;CXCL3
Tangier disease ORPHA:31150	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	MAFB;SOD2
Fatal familial insomnia ORPHA:466	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	RCAN1;DNAJB4
Fibrodysplasia ossificans progressiva ORPHA:337	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	SDC4;THBS1
USP18 deficiency ORPHA:481665	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	CXCL10;CXCL11
Ulnar-mammary syndrome ORPHA:3138	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	ID1;BDKRB2
Gerstmann-Straussler-Scheinker syndrome ORPHA:356	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	RCAN1;DNAJB4
WHIM syndrome ORPHA:51636	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	CCL4;LTB
Glycogen storage disease due to glycogen branching enzyme deficiency, adult neuromuscular form ORPHA:308712	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	DNAJB4;S100A3
Glycogen storage disease due to glycogen branching enzyme deficiency, childhood combined hepatic and myopathic form ORPHA:308684	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	DNAJB4;S100A3
Glycogen storage disease due to glycogen branching enzyme deficiency, childhood neuromuscular form ORPHA:308698	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	DNAJB4;S100A3
Glycogen storage disease due to glycogen branching enzyme deficiency, congenital neuromuscular form ORPHA:308670	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	DNAJB4;S100A3
Glycogen storage disease due to glycogen branching enzyme deficiency, fatal perinatal neuromuscular form ORPHA:308655	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	DNAJB4;S100A3
Glycogen storage disease due to glycogen branching enzyme deficiency, non progressive hepatic form ORPHA:308638	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	DNAJB4;S100A3
Glycogen storage disease due to glycogen branching enzyme deficiency, progressive hepatic form ORPHA:308621	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	DNAJB4;S100A3
Glycogen storage disease due to liver glycogen phosphorylase deficiency ORPHA:369	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	TNFAIP2;ADM
Hajdu-Cheney syndrome ORPHA:955	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	CYP1B1;THBS1
Hemochromatosis type 3 ORPHA:225123	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	MASP2;INHBC
Huntington disease-like 1 ORPHA:157941	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	RCAN1;DNAJB4
Hypermethioninemia due to glycine N-methyltransferase deficiency ORPHA:289891	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	MASP2;INHBC
Hyperprolinemia type 1 ORPHA:419	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	HAP1;GPM6B
Hypocalcemic vitamin D-resistant rickets ORPHA:93160	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	TOR4A;TICAM1
Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome ORPHA:69735	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	C11ORF96;ID1
Immunodeficiency due to MASP-2 deficiency ORPHA:331187	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	MASP2;INHBC
Infantile systemic hyalinosis ORPHA:2176	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	IL1B;ETS1
Inherited Creutzfeldt-Jakob disease ORPHA:282166	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	RCAN1;DNAJB4
Intrauterine growth restriction-short stature-early adult-onset diabetes syndrome ORPHA:436144	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	MAFB;TMEM88
Isolated hyperchlorhidrosis ORPHA:542657	2/101	0.15232903573877726	0.4838060079820406	0	0	2.9575757575757575	5.565306944242516	SDC4;BDKRB2
Juvenile glaucoma ORPHA:98977	2/102	0.15471485015711253	0.4838060079820406	0	0	2.9278518518518517	5.463873778039772	CYP1B1;CCL2
Acral peeling skin syndrome ORPHA:263534	2/102	0.15471485015711253	0.4838060079820406	0	0	2.9278518518518517	5.463873778039772	IL1B;PTAFR
Adenosine monophosphate deaminase deficiency ORPHA:45	2/102	0.15471485015711253	0.4838060079820406	0	0	2.9278518518518517	5.463873778039772	IRF1;PTAFR
NON RARE IN EUROPE: Idiopathic infantile nystagmus ORPHA:651	2/102	0.15471485015711253	0.4838060079820406	0	0	2.9278518518518517	5.463873778039772	RASL11B;PLK2
Axenfeld anomaly ORPHA:98978	2/102	0.15471485015711253	0.4838060079820406	0	0	2.9278518518518517	5.463873778039772	ID1;DKK1
Axenfeld-Rieger syndrome ORPHA:782	2/102	0.15471485015711253	0.4838060079820406	0	0	2.9278518518518517	5.463873778039772	ID1;DKK1
Nasu-Hakola disease ORPHA:2770	2/102	0.15471485015711253	0.4838060079820406	0	0	2.9278518518518517	5.463873778039772	PTAFR;CCL4
Neonatal inflammatory skin and bowel disease ORPHA:294023	2/102	0.15471485015711253	0.4838060079820406	0	0	2.9278518518518517	5.463873778039772	PLK2;DKK1
Palmoplantar keratoderma-deafness syndrome ORPHA:2202	2/102	0.15471485015711253	0.4838060079820406	0	0	2.9278518518518517	5.463873778039772	SDC4;CFB
Paternal uniparental disomy of chromosome 6 ORPHA:96191	2/102	0.15471485015711253	0.4838060079820406	0	0	2.9278518518518517	5.463873778039772	ITPRIP;STX11
Pediatric hepatocellular carcinoma ORPHA:33402	2/102	0.15471485015711253	0.4838060079820406	0	0	2.9278518518518517	5.463873778039772	SDC4;PLK2
Restrictive dermopathy ORPHA:1662	2/102	0.15471485015711253	0.4838060079820406	0	0	2.9278518518518517	5.463873778039772	SDC4;S100A3
Rieger anomaly ORPHA:91483	2/102	0.15471485015711253	0.4838060079820406	0	0	2.9278518518518517	5.463873778039772	ID1;DKK1
Short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemia ORPHA:632	2/102	0.15471485015711253	0.4838060079820406	0	0	2.9278518518518517	5.463873778039772	PTAFR;STX11
Familial isolated hypoparathyroidism due to impaired PTH secretion ORPHA:189466	2/102	0.15471485015711253	0.4838060079820406	0	0	2.9278518518518517	5.463873778039772	TNFSF14;CCL5
Trichorhinophalangeal syndrome type 2 ORPHA:502	2/102	0.15471485015711253	0.4838060079820406	0	0	2.9278518518518517	5.463873778039772	PLK2;THBS1
HELLP syndrome ORPHA:244242	2/102	0.15471485015711253	0.4838060079820406	0	0	2.9278518518518517	5.463873778039772	SERPINA3;CFB
Hutchinson-Gilford progeria syndrome ORPHA:740	2/102	0.15471485015711253	0.4838060079820406	0	0	2.9278518518518517	5.463873778039772	SDC4;S100A3
Imerslund-Grasbeck syndrome ORPHA:35858	2/102	0.15471485015711253	0.4838060079820406	0	0	2.9278518518518517	5.463873778039772	IRF1;LTB
Adult-onset myasthenia gravis ORPHA:391490	2/103	0.15710793948054458	0.4838060079820406	0	0	2.8987165383204987	5.365008912651797	CCL5;CCL4
Autosomal dominant secondary polycythemia ORPHA:247511	2/103	0.15710793948054458	0.4838060079820406	0	0	2.8987165383204987	5.365008912651797	SERPINA3;CFB
Cold-induced sweating syndrome ORPHA:157820	2/103	0.15710793948054458	0.4838060079820406	0	0	2.8987165383204987	5.365008912651797	S100A3;DKK1
Congenital vertebral-cardiac-renal anomalies syndrome ORPHA:521438	2/103	0.15710793948054458	0.4838060079820406	0	0	2.8987165383204987	5.365008912651797	TNFSF14;PTAFR
Dehydrated hereditary stomatocytosis ORPHA:3202	2/103	0.15710793948054458	0.4838060079820406	0	0	2.8987165383204987	5.365008912651797	TOR4A;IRF1
Dysosteosclerosis ORPHA:1782	2/103	0.15710793948054458	0.4838060079820406	0	0	2.8987165383204987	5.365008912651797	TOR4A;TICAM1
Erythrokeratodermia variabilis ORPHA:317	2/103	0.15710793948054458	0.4838060079820406	0	0	2.8987165383204987	5.365008912651797	SDC4;BDKRB2
Squamous cell carcinoma of salivary glands ORPHA:500481	2/103	0.15710793948054458	0.4838060079820406	0	0	2.8987165383204987	5.365008912651797	ITPRIP;IRF1
Squamous cell carcinoma of the hypopharynx ORPHA:494547	2/103	0.15710793948054458	0.4838060079820406	0	0	2.8987165383204987	5.365008912651797	ITPRIP;IRF1
Squamous cell carcinoma of the larynx ORPHA:494550	2/103	0.15710793948054458	0.4838060079820406	0	0	2.8987165383204987	5.365008912651797	ITPRIP;IRF1
Squamous cell carcinoma of the lip ORPHA:502366	2/103	0.15710793948054458	0.4838060079820406	0	0	2.8987165383204987	5.365008912651797	ITPRIP;IRF1
Squamous cell carcinoma of the nasal cavity and paranasal sinuses ORPHA:500464	2/103	0.15710793948054458	0.4838060079820406	0	0	2.8987165383204987	5.365008912651797	ITPRIP;IRF1
Squamous cell carcinoma of the oral cavity ORPHA:502363	2/103	0.15710793948054458	0.4838060079820406	0	0	2.8987165383204987	5.365008912651797	ITPRIP;IRF1
Squamous cell carcinoma of the oropharynx ORPHA:500478	2/103	0.15710793948054458	0.4838060079820406	0	0	2.8987165383204987	5.365008912651797	ITPRIP;IRF1
Familial platelet disorder with associated myeloid malignancy ORPHA:71290	2/103	0.15710793948054458	0.4838060079820406	0	0	2.8987165383204987	5.365008912651797	IRF1;NFKBIZ
High grade B-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement ORPHA:480541	2/103	0.15710793948054458	0.4838060079820406	0	0	2.8987165383204987	5.365008912651797	IRF1;STX11
Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections syndrome ORPHA:238569	2/103	0.15710793948054458	0.4838060079820406	0	0	2.8987165383204987	5.365008912651797	CCL5;CCL4
COFS syndrome ORPHA:1466	2/104	0.15950809433469024	0.4838060079820406	0	0	2.8701525054466233	5.268625898553727	GAPDHS;C10ORF55
Complete hydatidiform mole ORPHA:254688	2/104	0.15950809433469024	0.4838060079820406	0	0	2.8701525054466233	5.268625898553727	CCL4;LTB
Progressive symmetric erythrokeratodermia ORPHA:316	2/104	0.15950809433469024	0.4838060079820406	0	0	2.8701525054466233	5.268625898553727	SDC4;BDKRB2
Renal tubular dysgenesis of genetic origin ORPHA:97369	2/104	0.15950809433469024	0.4838060079820406	0	0	2.8701525054466233	5.268625898553727	SERPINA3;CFB
Epidermodysplasia verruciformis ORPHA:302	2/104	0.15950809433469024	0.4838060079820406	0	0	2.8701525054466233	5.268625898553727	IRF1;LTB
Peters anomaly ORPHA:708	2/105	0.16191510783845733	0.48787578546061483	0	0	2.842143113987774	5.1746419547106255	CYP1B1;DKK1
Fetal and neonatal alloimmune thrombocytopenia ORPHA:853	2/105	0.16191510783845733	0.48787578546061483	0	0	2.842143113987774	5.1746419547106255	THBS1;CXCL5
Limited cutaneous systemic sclerosis ORPHA:220402	2/106	0.16432877560455972	0.491912282528682	0	0	2.8146723646723646	5.0829777800563765	IRF1;PTAFR
Adams-Oliver syndrome ORPHA:974	2/106	0.16432877560455972	0.491912282528682	0	0	2.8146723646723646	5.0829777800563765	PLAU;CCL2
NON RARE IN EUROPE: Age-related macular degeneration ORPHA:279	2/107	0.16674889563595052	0.4927160916210667	0	0	2.787724867724868	4.9935573780727	SERPINA3;CFB
Oligoarticular juvenile idiopathic arthritis ORPHA:85410	2/107	0.16674889563595052	0.4927160916210667	0	0	2.787724867724868	4.9935573780727	CCL5;LTB
Rheumatoid factor-negative polyarticular juvenile idiopathic arthritis ORPHA:85408	2/107	0.16674889563595052	0.4927160916210667	0	0	2.787724867724868	4.9935573780727	CCL5;LTB
Hypomaturation amelogenesis imperfecta ORPHA:100033	2/107	0.16674889563595052	0.4927160916210667	0	0	2.787724867724868	4.9935573780727	TNFSF14;PTAFR
Juvenile myoclonic epilepsy ORPHA:307	2/108	0.16917526840701474	0.49827828251069295	0	0	2.7612858141160026	4.906307888681078	UNC13A;GPM6B
Common variable immunodeficiency ORPHA:1572	2/110	0.1740459858963565	0.5109811637213543	0	0	2.7098765432098766	4.738044966412776	CCL4;LTB
Giant cell glioblastoma ORPHA:251579	2/112	0.17893937908653246	0.5220015007747252	0	0	2.6603367003367	4.577663161255457	NFKBIA;LIF
Gliosarcoma ORPHA:251576	2/112	0.17893937908653246	0.5220015007747252	0	0	2.6603367003367	4.577663161255457	NFKBIA;LIF
NON RARE IN EUROPE: Autism ORPHA:106	2/115	0.18631868889112638	0.5312419675785659	0	0	2.58931497869551	4.350817388838029	UNC13A;GPM6B
Primary ciliary dyskinesia ORPHA:244	2/136	0.2389136808292667	0.5312419675785659	0	0	2.1812050856826977	3.1227287180828056	CCDC39;FOXJ1
Hairy cell leukemia variant ORPHA:300878	1/69	0.37816856748681427	0.5312419675785659	0	0	2.140462802768166	2.0814186437173	LTB
Arthrogryposis-renal dysfunction-cholestasis syndrome ORPHA:2697	1/100	0.49795639252529783	0.5312419675785659	0	0	1.467914438502674	1.0234927306951356	FKBPL
Atypical hemolytic uremic syndrome with anti-factor H antibodies ORPHA:93581	1/100	0.49795639252529783	0.5312419675785659	0	0	1.467914438502674	1.0234927306951356	INHBC
Autosomal dominant primary hypomagnesemia with hypocalciuria ORPHA:34528	1/100	0.49795639252529783	0.5312419675785659	0	0	1.467914438502674	1.0234927306951356	SCTR
Multicentric osteolysis-nodulosis-arthropathy spectrum ORPHA:371428	1/100	0.49795639252529783	0.5312419675785659	0	0	1.467914438502674	1.0234927306951356	PLAU
Multiple osteochondromas ORPHA:321	1/100	0.49795639252529783	0.5312419675785659	0	0	1.467914438502674	1.0234927306951356	DKK1
Neu-Laxova syndrome ORPHA:2671	1/100	0.49795639252529783	0.5312419675785659	0	0	1.467914438502674	1.0234927306951356	CHAC1
C3 glomerulonephritis ORPHA:329931	1/100	0.49795639252529783	0.5312419675785659	0	0	1.467914438502674	1.0234927306951356	INHBC
C3 glomerulopathy ORPHA:329918	1/100	0.49795639252529783	0.5312419675785659	0	0	1.467914438502674	1.0234927306951356	INHBC
Pitt-Hopkins-like syndrome ORPHA:221150	1/100	0.49795639252529783	0.5312419675785659	0	0	1.467914438502674	1.0234927306951356	GPM6B
Rotor syndrome ORPHA:3111	1/100	0.49795639252529783	0.5312419675785659	0	0	1.467914438502674	1.0234927306951356	INHBC
DEND syndrome ORPHA:79134	1/100	0.49795639252529783	0.5312419675785659	0	0	1.467914438502674	1.0234927306951356	UNC13A
Deafness-infertility syndrome ORPHA:94064	1/100	0.49795639252529783	0.5312419675785659	0	0	1.467914438502674	1.0234927306951356	L3MBTL1
Simpson-Golabi-Behmel syndrome ORPHA:373	1/100	0.49795639252529783	0.5312419675785659	0	0	1.467914438502674	1.0234927306951356	RASL11B
T-B+ severe combined immunodeficiency due to CD3delta/CD3epsilon/CD3zeta ORPHA:169160	1/100	0.49795639252529783	0.5312419675785659	0	0	1.467914438502674	1.0234927306951356	LTB
Immunodeficiency due to a classical component pathway complement deficiency ORPHA:169147	1/100	0.49795639252529783	0.5312419675785659	0	0	1.467914438502674	1.0234927306951356	CFB
Intermediate generalized junctional epidermolysis bullosa ORPHA:79402	1/100	0.49795639252529783	0.5312419675785659	0	0	1.467914438502674	1.0234927306951356	SDC4
12p12.1 microdeletion syndrome ORPHA:313884	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	GPM6B
Isolated thyroid-stimulating hormone deficiency ORPHA:90674	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	RGS2
1p21.3 microdeletion syndrome ORPHA:293948	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	IRF1
20p12.3 microdeletion syndrome ORPHA:261295	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	ID1
KCNQ2-related epileptic encephalopathy ORPHA:439218	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	UNC13A
3-phosphoglycerate dehydrogenase deficiency, infantile/juvenile form ORPHA:79351	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	CHAC1
46,XY disorder of sex development due to 17-beta-hydroxysteroid dehydrogenase 3 deficiency ORPHA:752	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	SERPINA3
46,XY gonadal dysgenesis-motor and sensory neuropathy syndrome ORPHA:168563	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	C11ORF96
Keutel syndrome ORPHA:85202	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	SERPINA3
Kniest dysplasia ORPHA:485	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	RASL11B
Kyphoscoliosis-lateral tongue atrophy-hereditary spastic paraplegia syndrome ORPHA:496689	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	SOD2
ABeta amyloidosis, Arctic type ORPHA:324723	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	PLK2
ABeta amyloidosis, Dutch type ORPHA:100006	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	PLK2
ABeta amyloidosis, Iowa type ORPHA:324708	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	PLK2
Kyphosis-lateral tongue atrophy-myofibrillar myopathy syndrome ORPHA:496686	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	SOD2
ABeta amyloidosis, Italian type ORPHA:324713	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	PLK2
ABetaA21G amyloidosis ORPHA:324718	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	PLK2
ABetaL34V amyloidosis ORPHA:324703	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	PLK2
ACys amyloidosis ORPHA:100008	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	MAFB
LAMA5-related multisystemic syndrome ORPHA:521450	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	ID1
LRP5-related primary osteoporosis ORPHA:498481	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	ID1
ALys amyloidosis ORPHA:93561	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	PTAFR
ANK3-related intellectual disability-sleep disturbance syndrome ORPHA:356996	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	GPM6B
Late-onset retinal degeneration ORPHA:67042	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	C11ORF96
Ablepharon macrostomia syndrome ORPHA:920	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	BDKRB2
Legg-Calve-Perthes disease ORPHA:2380	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	RASL11B
Achondrogenesis type 2 ORPHA:93296	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	RASL11B
Achondroplasia ORPHA:15	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	ID1
Lethal congenital contracture syndrome type 1 ORPHA:1486	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	FKBPL
Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome ORPHA:2570	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	FKBPL
Leukoencephalopathy with mild cerebellar ataxia and white matter edema ORPHA:363540	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	HAP1
Leydig cell hypoplasia due to LHB deficiency ORPHA:325448	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	GAPDHS
Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins ORPHA:217371	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	GAPDHS
Acute intermittent porphyria ORPHA:79276	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	FKBPL
Acute mast cell leukemia ORPHA:566393	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	GPM6B
Limited systemic sclerosis ORPHA:220407	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	CCL4
Lissencephaly type 1 due to doublecortin gene mutation ORPHA:2148	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	GPM6B
Lymphedema-distichiasis syndrome ORPHA:33001	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	DKK1
Lysinuric protein intolerance ORPHA:470	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	PTAFR
Adult-onset autosomal recessive cerebellar ataxia ORPHA:284289	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	SDC4
Alagille syndrome due to 20p12 microdeletion ORPHA:261600	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	PLK2
Alagille syndrome due to a JAG1 point mutation ORPHA:261619	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	PLK2
MME-related autosomal dominant Charcot Marie Tooth disease type 2 ORPHA:497757	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	ADM
MPDU1-CDG ORPHA:79323	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	FKBPL
MRCS syndrome ORPHA:263347	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	SOD2
Alopecia universalis ORPHA:701	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	BDKRB2
Alpha-1-antitrypsin deficiency ORPHA:60	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	PTAFR
Macrocephaly-developmental delay syndrome ORPHA:397612	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	FKBPL
Male infertility with teratozoospermia due to single gene mutation ORPHA:399808	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	NANOS1
Anophthalmia/microphthalmia-esophageal atresia syndrome ORPHA:77298	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	GPM6B
Argininemia ORPHA:90	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	MASP2
Arthrogryposis-anterior horn cell disease syndrome ORPHA:53696	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	FKBPL
Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency ORPHA:319552	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	CCL5
Mendelian susceptibility to mycobacterial diseases due to partial IRF8 deficiency ORPHA:319600	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	CCL4
Menstrual cycle-dependent periodic fever ORPHA:498251	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	UNC13A
Atrichia with papular lesions ORPHA:86819	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	BDKRB2
Atypical Gaucher disease due to saposin C deficiency ORPHA:309252	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	MAFB
Metatropic dysplasia ORPHA:2635	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	SDC4
Methylmalonic acidemia with homocystinuria, type cblJ ORPHA:369955	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	SPG7
Auditory neuropathy-optic atrophy syndrome ORPHA:542585	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	FKBPL
Autism spectrum disorder due to AUTS2 deficiency ORPHA:352490	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	GPM6B
Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsuffiency ORPHA:436159	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	LTB
Autosomal dominant Charcot-Marie-Tooth disease type 2 due to DGAT2 mutation ORPHA:487814	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	PTAFR
Autosomal dominant Charcot-Marie-Tooth disease type 2 due to KIF5A mutation ORPHA:324611	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	UNC13A
Autosomal dominant Charcot-Marie-Tooth disease type 2B ORPHA:99936	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	TICAM1
Autosomal dominant Charcot-Marie-Tooth disease type 2C ORPHA:99937	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	SDC4
Autosomal dominant Charcot-Marie-Tooth disease type 2D ORPHA:99938	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	CHAC1
Autosomal dominant Charcot-Marie-Tooth disease type 2F ORPHA:99940	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	SDC4
Microcytic anemia with liver iron overload ORPHA:83642	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	CFB
Autosomal dominant Charcot-Marie-Tooth disease type 2I ORPHA:99942	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	STAT5A
Autosomal dominant Charcot-Marie-Tooth disease type 2J ORPHA:99943	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	STAT5A
Autosomal dominant Charcot-Marie-Tooth disease type 2K ORPHA:99944	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	UNC13A
Microphthalmia with brain and digit anomalies ORPHA:139471	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	ID1
Autosomal dominant Charcot-Marie-Tooth disease type 2N ORPHA:228174	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	CHAC1
Autosomal dominant Charcot-Marie-Tooth disease type 2U ORPHA:397735	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	CHAC1
Mild hemophilia B ORPHA:169799	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	INHBC
Autosomal dominant brachyolmia ORPHA:93304	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	SDC4
Mild spondyloepiphyseal dysplasia due to COL2A1 mutation with early-onset osteoarthritis ORPHA:93279	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	RASL11B
Autosomal dominant congenital benign spinal muscular atrophy ORPHA:1216	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	SDC4
Autosomal dominant focal dystonia, DYT25 type ORPHA:329466	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	GPM6B
Autosomal dominant hyperinsulinism due to SUR1 deficiency ORPHA:276575	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	UNC13A
Miyoshi myopathy ORPHA:45448	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	TNFAIP2
Moderately severe hemophilia B ORPHA:169796	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	INHBC
Autosomal dominant intermediate Charcot-Marie-Tooth disease type C ORPHA:100045	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	CHAC1
Autosomal dominant intermediate Charcot-Marie-Tooth disease type D ORPHA:100046	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	STAT5A
Autosomal dominant intermediate Charcot-Marie-Tooth disease with neuropathic pain ORPHA:324585	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	STAT5A
Monosomy 9q22.3 ORPHA:77301	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	GPM6B
Autosomal dominant multiple pterygium syndrome ORPHA:65743	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	MASP2
Autosomal dominant osteopetrosis type 1 ORPHA:2783	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	ID1
Mucolipidosis type IV ORPHA:578	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	TICAM1
Autosomal dominant preaxial polydactyly-upperback hypertrichosis syndrome ORPHA:476119	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	RND1
Mucopolysaccharidosis type 6, rapidly progressing ORPHA:276212	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	ITPRIP
Mucopolysaccharidosis type 6, slowly progressing ORPHA:276223	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	ITPRIP
Autosomal dominant rhegmatogenous retinal detachment ORPHA:209867	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	RASL11B
Muenke syndrome ORPHA:53271	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	ID1
Multicentric carpo-tarsal osteolysis with or without nephropathy ORPHA:2774	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	MAFB
Autosomal dominant spastic paraplegia type 10 ORPHA:100991	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	UNC13A
Autosomal dominant spastic paraplegia type 3 ORPHA:100984	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	GPM6B
Autosomal dominant spastic paraplegia type 73 ORPHA:444099	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	UNC13A
Autosomal dominant striatal neurodegeneration ORPHA:228169	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	GPM6B
Multiple epiphyseal dysplasia type 5 ORPHA:93311	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	DKK1
Autosomal dominant vitreoretinochoroidopathy ORPHA:3086	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	SOD2
Multiple epiphyseal dysplasia, Beighton type ORPHA:166011	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	RASL11B
Multiple intestinal atresia ORPHA:2300	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	IRF1
Autosomal recessive Charcot-Marie-Tooth disease with hoarseness ORPHA:101097	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	UNC13A
Autosomal recessive anterior segment dysgenesis ORPHA:519388	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	L3MBTL1
Autosomal recessive bestrophinopathy ORPHA:139455	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	SOD2
Autosomal recessive cerebellar ataxia-psychomotor delay syndrome ORPHA:284271	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	UNC13A
Autosomal recessive cutis laxa type 2B ORPHA:357064	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	CHAC1
Autosomal recessive hyperinsulinism due to SUR1 deficiency ORPHA:79643	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	UNC13A
Autosomal recessive intermediate Charcot-Marie-Tooth disease type A ORPHA:217055	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	UNC13A
NLRC4-related familial cold autoinflammatory syndrome ORPHA:576349	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	PTAFR
NON RARE IN EUROPE: Berger disease ORPHA:34145	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	MAFB
Autosomal recessive primary immunodeficiency with defective spontaneous natural killer cell cytotoxicity ORPHA:437552	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	CCL4
NON RARE IN EUROPE: Congenital isolated thyroxine-binding globulin deficiency ORPHA:209893	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	INHBC
Autosomal recessive severe congenital neutropenia due to CXCR2 deficiency ORPHA:420699	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	PTAFR
NON RARE IN EUROPE: Familial dysalbuminemic hyperthyroxinemia ORPHA:276271	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	INHBC
NON RARE IN EUROPE: Hemochromatosis type 1 ORPHA:139498	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	TNFAIP2
Autosomal recessive spastic paraplegia type 53 ORPHA:319199	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	DNAJB4
NON RARE IN EUROPE: Non rare obesity ORPHA:521399	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	UNC13A
Autosomal recessive spastic paraplegia type 5A ORPHA:100986	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	CX3CL1
NON RARE IN EUROPE: Parkinson disease ORPHA:319705	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	TICAM1
Autosomal recessive spastic paraplegia type 67 ORPHA:401820	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	GPM6B
Autosomal recessive spastic paraplegia type 70 ORPHA:401835	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	CHAC1
NON RARE IN EUROPE: Rheumatoid arthritis ORPHA:284130	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	CCL4
NON RARE IN EUROPE: Trimethylaminuria ORPHA:35056	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	CFB
Autosomal spastic paraplegia type 30 ORPHA:101010	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	UNC13A
Autosomal spastic paraplegia type 72 ORPHA:401849	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	UNC13A
Ayme-Gripp syndrome ORPHA:1272	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	MAFB
BENTA disease ORPHA:464336	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	LTB
BICD2-related autosomal dominant childhood-onset proximal spinal muscular atrophy ORPHA:363454	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	ITPRIP
Neonatal alloimmune neutropenia ORPHA:464370	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	PTAFR
Neonatal ichthyosis-sclerosing cholangitis syndrome ORPHA:59303	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	SDC4
Barber-Say syndrome ORPHA:1231	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	BDKRB2
Nephrotic syndrome-epidermolysis bullosa-sensorineural deafness syndrome ORPHA:300333	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	SDC4
Neurodegenerative syndrome due to cerebral folate transport deficiency ORPHA:217382	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	SDC4
Best vitelliform macular dystrophy ORPHA:1243	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	SOD2
Neutral lipid storage disease with ichthyosis ORPHA:98907	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	STX11
Neutral lipid storage myopathy ORPHA:98908	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	TICAM1
Beta-ureidopropionase deficiency ORPHA:65287	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	TNFSF14
Bilateral generalized polymicrogyria ORPHA:208447	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	UNC13A
Nodular urticaria pigmentosa ORPHA:158772	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	GPM6B
Biotin-thiamine-responsive basal ganglia disease ORPHA:65284	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	SCTR
Non-epidermolytic palmoplantar keratoderma ORPHA:2337	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	FOXJ1
Birt-Hogg-Dube syndrome ORPHA:122	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	SPG7
Bleeding diathesis due to thromboxane synthesis deficiency ORPHA:220443	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	CCL5
Bleeding disorder due to CalDAG-GEFI deficiency ORPHA:420566	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	LTB
Blepharophimosis-ptosis-epicanthus inversus syndrome plus ORPHA:572333	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	DKK1
Blepharophimosis-ptosis-epicanthus inversus syndrome type 1 ORPHA:572354	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	DKK1
Norrie disease ORPHA:649	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	CAMK1G
Blepharophimosis-ptosis-epicanthus inversus syndrome type 2 ORPHA:572361	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	DKK1
Null syndrome ORPHA:280234	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	GPM6B
Obesity due to leptin receptor gene deficiency ORPHA:179494	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	DNAJB4
Bothnia retinal dystrophy ORPHA:85128	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	GPM6B
Brachydactyly type B1 ORPHA:572385	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	RASL11B
Brain demyelination due to methionine adenosyltransferase deficiency ORPHA:168598	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	INHBC
Oculocutaneous albinism type 6 ORPHA:370097	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	GPM6B
Branchio-oculo-facial syndrome ORPHA:1297	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	DKK1
Bullous diffuse cutaneous mastocytosis ORPHA:280785	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	GPM6B
C syndrome ORPHA:1308	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	LTB
C1 inhibitor deficiency ORPHA:459353	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	MAFB
Optic atrophy-ataxia-peripheral neuropathy-global developmental delay syndrome ORPHA:543470	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	FKBPL
CCDC115-CDG ORPHA:468684	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	DEDD2
CHILD syndrome ORPHA:139	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	FKBPL
CK syndrome ORPHA:251383	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	FKBPL
Osteogenesis imperfecta type 5 ORPHA:216828	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	LTB
CLN2 disease ORPHA:228349	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	TICAM1
CLN3 disease ORPHA:228346	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	IRF1
Osteopetrosis with renal tubular acidosis ORPHA:2785	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	PTAFR
Osteoporosis-pseudoglioma syndrome ORPHA:2788	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	ID1
Osteosclerosis-developmental delay-craniosynostosis syndrome ORPHA:178377	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	ID1
PDE4D haploinsufficiency syndrome ORPHA:439822	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	NCOA7
Camptodactyly-tall stature-scoliosis-hearing loss syndrome ORPHA:85164	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	ID1
PLG-related hereditary angioedema with normal C1Inh ORPHA:537072	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	MASP2
PLIN1-related familial partial lipodystrophy ORPHA:280356	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	SERPINA3
PMP2-related Charcot-Marie-Tooth disease type 1 ORPHA:476394	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	GPM6B
Carnitine palmitoyl transferase 1A deficiency ORPHA:156	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	TICAM1
PYCR1-related De Barsy syndrome ORPHA:293633	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	CHAC1
Caroli disease ORPHA:53035	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	SCTR
Carvajal syndrome ORPHA:65282	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	SDC4
Cathepsin A-related arteriopathy-strokes-leukoencephalopathy ORPHA:575553	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	TICAM1
Pancreatic hypoplasia-diabetes-congenital heart disease syndrome ORPHA:2255	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	ID1
Cerebellar ataxia, Cayman type ORPHA:94122	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	UNC13A
Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome ORPHA:1171	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	UNC13A
Parastremmatic dwarfism ORPHA:2646	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	SDC4
Parietal foramina with clavicular hypoplasia ORPHA:251290	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	DKK1
Cerebrotendinous xanthomatosis ORPHA:909	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	MAFB
Charcot-Marie-Tooth disease type 1B ORPHA:101082	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	STAT5A
Charcot-Marie-Tooth disease type 2H ORPHA:101102	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	UNC13A
Pelizaeus-Merzbacher disease in female carriers ORPHA:280229	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	GPM6B
Pelizaeus-Merzbacher disease, classic form ORPHA:280219	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	GPM6B
Pelizaeus-Merzbacher disease, connatal form ORPHA:280210	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	GPM6B
Pelizaeus-Merzbacher disease, transitional form ORPHA:280224	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	GPM6B
Charcot-Marie-Tooth disease type 2T ORPHA:495274	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	ADM
Charcot-Marie-Tooth disease type 4A ORPHA:99948	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	UNC13A
Periodic fever-infantile enterocolitis-autoinflammatory syndrome ORPHA:436166	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	PTAFR
Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease ORPHA:163746	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	GPM6B
Cherubism ORPHA:184	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	PTAFR
Childhood-onset autosomal recessive slowly progressive spinocerebellar ataxia ORPHA:284324	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	TICAM1
Peroxisomal acyl-CoA oxidase deficiency ORPHA:2971	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	SOD2
Persistent polyclonal B-cell lymphocytosis ORPHA:300324	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	LTB
Chondrodysplasia-disorder of sex development syndrome ORPHA:1422	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	PLK2
Phocomelia, Schinzel type ORPHA:2879	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	NUAK2
Phosphoserine aminotransferase deficiency, infantile/juvenile form ORPHA:284417	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	CHAC1
Chronic beryllium disease ORPHA:133	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	CCL4
Chronic enteropathy associated with SLCO2A1 gene ORPHA:468641	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	BDKRB2
Chronic mast cell leukemia ORPHA:566396	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	GPM6B
Plaque-form urticaria pigmentosa ORPHA:158769	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	GPM6B
Platyspondylic dysplasia, Torrance type ORPHA:85166	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	RASL11B
Chronic respiratory distress with surfactant metabolism deficiency ORPHA:217566	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	CX3CL1
Polydactyly of a biphalangeal thumb ORPHA:93339	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	ITPRIP
Polyglucosan body myopathy type 1 ORPHA:397937	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	TICAM1
Pontocerebellar hypoplasia type 10 ORPHA:411493	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	FKBPL
Classical-like Ehlers-Danlos syndrome type 2 ORPHA:536532	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	C11ORF96
Coats disease ORPHA:190	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	CAMK1G
Colobomatous macrophthalmia-microcornea syndrome ORPHA:468672	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	PLK2
Combined immunodeficiency due to CD27 deficiency ORPHA:238505	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	LTB
Combined immunodeficiency due to CD3gamma deficiency ORPHA:169082	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	CCL5
Combined immunodeficiency due to CD70 deficiency ORPHA:538958	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	IL23A
Primary dystonia, DYT2 type ORPHA:99657	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	UNC13A
Combined immunodeficiency due to ZAP70 deficiency ORPHA:911	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	LTB
Combined immunodeficiency-enteropathy spectrum ORPHA:436252	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	IRF1
Primary hypomagnesemia with secondary hypocalcemia ORPHA:30924	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	PTAFR
Progressive autosomal recessive ataxia-deafness syndrome ORPHA:448251	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	TICAM1
Combined oxidative phosphorylation defect type 8 ORPHA:319504	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	GAPDHS
Progressive essential tremor-speech impairment-facial dysmorphism-intellectual disability-abnormal behavior syndrome ORPHA:457212	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	UNC13A
Progressive familial intrahepatic cholestasis type 4 ORPHA:480483	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	SDC4
Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency ORPHA:90795	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	CCL5
Progressive myoclonic epilepsy type 7 ORPHA:435438	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	UNC13A
Progressive myoclonic epilepsy with dystonia ORPHA:352596	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	UNC13A
Congenital alveolar capillary dysplasia ORPHA:210122	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	C11ORF96
Congenital analbuminemia ORPHA:86816	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	INHBC
Congenital atransferrinemia ORPHA:1195	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	SERPINA3
Progressive retinal dystrophy due to retinol transport defect ORPHA:352718	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	SERPINA3
Congenital bile acid synthesis defect type 2 ORPHA:79303	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	INHBC
Congenital bile acid synthesis defect type 3 ORPHA:79302	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	CX3CL1
Congenital brain dysgenesis due to glutamine synthetase deficiency ORPHA:71278	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	MAFB
Congenital factor II deficiency ORPHA:325	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	INHBC
Congenital factor V deficiency ORPHA:326	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	TNFSF14
Pseudoxanthomatous diffuse cutaneous mastocytosis ORPHA:280794	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	GPM6B
Congenital hereditary facial paralysis-variable hearing loss syndrome ORPHA:306530	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	FOXJ1
Congenital isolated ACTH deficiency ORPHA:199296	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	TNF
Congenital lethal myopathy, Compton-North type ORPHA:210163	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	GPM6B
Congenital membranous nephropathy due to fetomaternal anti-neutral endopeptidase alloimmunization ORPHA:69063	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	ADM
Pycnodysostosis ORPHA:763	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	CCL2
Congenital microcephaly-severe encephalopathy-progressive cerebral atrophy syndrome ORPHA:391376	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	CHAC1
Pyogenic arthritis-pyoderma gangrenosum-acne syndrome ORPHA:69126	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	LTB
Congenital myopathy, Paradas type ORPHA:199329	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	TNFAIP2
Congenital non-communicating hydrocephalus ORPHA:269510	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	LTB
REN-related autosomal dominant tubulointerstitial kidney disease ORPHA:217330	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	SDC4
RIN2 syndrome ORPHA:217335	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	THBS1
RNF13-related severe early-onset epileptic encephalopathy ORPHA:544503	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	PTAFR
Rapid-onset dystonia-parkinsonism ORPHA:71517	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	UNC13A
Recurrent Neisseria infections due to factor D deficiency ORPHA:169467	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	TNFAIP2
Cortical dysplasia-focal epilepsy syndrome ORPHA:163681	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	GPM6B
Resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta ORPHA:566243	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	SDC4
Craniodiaphyseal dysplasia ORPHA:1513	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	RASL11B
Craniolenticulosutural dysplasia ORPHA:50814	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	DNAJB4
Craniosynostosis, Boston type ORPHA:1541	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	DKK1
Crouzon syndrome-acanthosis nigricans syndrome ORPHA:93262	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	ID1
Cutaneous mastocytoma ORPHA:79455	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	GPM6B
Ring dermoid of cornea ORPHA:91481	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	DKK1
Rolandic epilepsy-paroxysmal exercise-induced dystonia-writer's cramp syndrome ORPHA:163727	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	UNC13A
DK1-CDG ORPHA:91131	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	FKBPL
DNAJB6-related  limb-girdle muscular dystrophy D1 ORPHA:34516	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	CXCL3
DOORS syndrome ORPHA:79500	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	UNC13A
SLC35A2-CDG ORPHA:356961	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	FKBPL
SLC39A8-CDG ORPHA:468699	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	CD83
Sanfilippo syndrome type C ORPHA:79271	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	MAFB
Sarcosinemia ORPHA:3129	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	INHBC
Scapuloperoneal spinal muscular atrophy ORPHA:431255	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	SDC4
Schilbach-Rott syndrome ORPHA:2353	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	GPM6B
Developmental and speech delay due to SOX5 deficiency ORPHA:313892	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	GPM6B
Diaphragmatic hernia-short bowel-asplenia syndrome ORPHA:527468	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	TNFAIP2
Diazoxide-resistant focal hyperinsulinism due to SUR1 deficiency ORPHA:276598	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	UNC13A
Dihydropyrimidine dehydrogenase deficiency ORPHA:1675	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	IRF1
Severe achondroplasia-developmental delay-acanthosis nigricans syndrome ORPHA:85165	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	ID1
Severe combined immunodeficiency due to CARD11 deficiency ORPHA:357237	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	LTB
Severe combined immunodeficiency due to CARMIL2 deficiency ORPHA:542301	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	LTB
Severe combined immunodeficiency due to CORO1A deficiency ORPHA:228003	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	LTB
Distal monosomy 15q ORPHA:1596	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	IRF1
Severe combined immunodeficiency due to IKK2 deficiency ORPHA:397787	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	IRF1
Distal myopathy with anterior tibial onset ORPHA:178400	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	TNFAIP2
Severe combined immunodeficiency due to LCK deficiency ORPHA:280142	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	LTB
Severe combined immunodeficiency due to adenosine deaminase deficiency ORPHA:277	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	IL23A
Severe congenital hypochromic anemia with ringed sideroblasts ORPHA:300298	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	SDC4
Donnai-Barrow syndrome ORPHA:2143	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	GPM6B
Severe early-onset pulmonary alveolar proteinosis due to MARS deficiency ORPHA:440427	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	CHAC1
Dopa-responsive dystonia due to sepiapterin reductase deficiency ORPHA:70594	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	SDC4
Dopamine beta-hydroxylase deficiency ORPHA:230	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	MASP2
Severe hemophilia B ORPHA:169793	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	INHBC
Duane retraction syndrome with congenital deafness ORPHA:529574	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	MAFB
Dysferlin-related  limb-girdle muscular dystrophy R2 ORPHA:268	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	TNFAIP2
Dysspondyloenchondromatosis ORPHA:85198	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	RASL11B
Severe primary trimethylaminuria ORPHA:468726	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	CFB
EAST syndrome ORPHA:199343	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	GPM6B
EMILIN-1-related connective tissue disease ORPHA:485418	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	C11ORF96
Short stature due to growth hormone qualitative anomaly ORPHA:629	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	LTB
Early-onset Lafora body disease ORPHA:324290	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	IL1B
Short stature due to primary acid-labile subunit deficiency ORPHA:140941	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	INHBC
Short stature-pituitary and cerebellar defects-small sella turcica syndrome ORPHA:85442	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	GAPDHS
Early-onset myopathy-areflexia-respiratory distress-dysphagia syndrome ORPHA:439212	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	GPM6B
Sialuria ORPHA:3166	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	CFB
Early-onset progressive encephalopathy-hearing loss-pons hypoplasia-brain atrophy syndrome ORPHA:500144	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	SPG7
East Texas bleeding disorder ORPHA:391320	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	TNFSF14
Embryonal rhabdomyosarcoma ORPHA:99757	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	TICAM1
Encephalopathy due to prosaposin deficiency ORPHA:139406	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	MAFB
Skin fragility-woolly hair-palmoplantar keratoderma syndrome ORPHA:293165	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	SDC4
Endosteal hyperostosis, Worth type ORPHA:2790	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	ID1
Smoldering systemic mastocytosis ORPHA:158775	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	GPM6B
Spastic paraplegia type 2 ORPHA:99015	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	GPM6B
Spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome ORPHA:447997	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	RCAN1
Spinal muscular atrophy-progressive myoclonic epilepsy syndrome ORPHA:2590	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	PTAFR
Erythrokeratodermia-cardiomyopathy syndrome ORPHA:476096	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	SDC4
Spinocerebellar ataxia type 1 ORPHA:98755	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	SOD2
Spinocerebellar ataxia type 14 ORPHA:98763	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	UNC13A
Spinocerebellar ataxia type 18 ORPHA:98771	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	RGS2
FADD-related immunodeficiency ORPHA:306550	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	FKBPL
Spinocerebellar ataxia type 4 ORPHA:98765	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	GAPDHS
Spinocerebellar ataxia type 40 ORPHA:423275	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	LTB
Spinocerebellar ataxia type 42 ORPHA:458803	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	UNC13A
Spinocerebellar ataxia type 43 ORPHA:497764	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	ADM
Familial Mediterranean fever ORPHA:342	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	PTAFR
Spondyloepimetaphyseal dysplasia congenita, Strudwick type ORPHA:93346	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	RASL11B
Familial apolipoprotein A5 deficiency ORPHA:530849	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	INHBC
Spondyloepimetaphyseal dysplasia, matrilin-3 type ORPHA:156728	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	DKK1
Spondyloepiphyseal dysplasia congenita ORPHA:94068	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	RASL11B
Spondyloepiphyseal dysplasia with metatarsal shortening ORPHA:137678	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	RASL11B
Spondyloepiphyseal dysplasia, Maroteaux type ORPHA:263482	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	SDC4
Spondyloepiphyseal dysplasia, Stanescu type ORPHA:459051	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	RASL11B
Spondylometaphyseal dysplasia, Kozlowski type ORPHA:93314	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	SDC4
Spondylometaphyseal dysplasia, Schmidt type ORPHA:93316	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	RASL11B
Spondyloperipheral dysplasia-short ulna syndrome ORPHA:1856	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	RASL11B
Sporadic porphyria cutanea tarda ORPHA:443057	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	TNFAIP2
Familial digital arthropathy-brachydactyly ORPHA:85169	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	SDC4
Familial episodic pain syndrome with predominantly upper body involvement ORPHA:391389	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	CCL2
Familial gastric type 1 neuroendocrine tumor ORPHA:464756	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	UNC13A
Stickler syndrome type 1 ORPHA:90653	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	RASL11B
Subcutaneous panniculitis-like T-cell lymphoma ORPHA:86884	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	CCL4
Familial hypocalciuric hypercalcemia type 1 ORPHA:93372	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	SCTR
Susceptibility to localized juvenile periodontitis ORPHA:447740	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	PTAFR
Susceptibility to respiratory infections associated with CD8alpha chain mutation ORPHA:169085	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	LTB
Sweet syndrome ORPHA:3243	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	PTAFR
Symptomatic form of hemochromatosis type 1 ORPHA:465508	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	TNFAIP2
Familial isolated trichomegaly ORPHA:411788	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	OXTR
Symptomatic form of hemophilia B in female carriers ORPHA:177929	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	INHBC
T-B+ severe combined immunodeficiency due to JAK3 deficiency ORPHA:35078	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	LTB
T-B+ severe combined immunodeficiency due to gamma chain deficiency ORPHA:276	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	LTB
T-cell immunodeficiency with epidermodysplasia verruciformis ORPHA:324294	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	LTB
Familial progressive hyper- and hypopigmentation ORPHA:280628	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	PLK2
Familial progressive hyperpigmentation ORPHA:79146	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	PLK2
TCR-alpha-beta-positive T-cell deficiency ORPHA:397959	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	LTB
Familial retinal arterial macroaneurysm ORPHA:284247	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	CCL2
Familial spontaneous pneumothorax ORPHA:2903	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	SPG7
Familial steroid-resistant nephrotic syndrome with adrenal insufficiency ORPHA:506334	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	SDC4
Tatton-Brown-Rahman syndrome ORPHA:404443	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	L3MBTL1
Farber disease ORPHA:333	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	PTAFR
Telangiectasia macularis eruptiva perstans ORPHA:90389	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	GPM6B
Fatal post-viral neurodegenerative disorder ORPHA:391343	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	LTB
Temtamy preaxial brachydactyly syndrome ORPHA:363417	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	ITPRIP
Fetal Gaucher disease ORPHA:85212	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	TICAM1
Testicular seminomatous germ cell tumor ORPHA:842	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	GPM6B
Thanatophoric dysplasia type 1 ORPHA:1860	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	ID1
Thanatophoric dysplasia type 2 ORPHA:93274	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	ID1
Thiamine-responsive encephalopathy ORPHA:199348	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	SCTR
Thrombocythemia with distal limb defects ORPHA:329319	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	INHBC
Focal epilepsy-intellectual disability-cerebro-cerebellar malformation ORPHA:352587	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	UNC13A
Focal facial dermal dysplasia type III ORPHA:1807	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	BDKRB2
Formiminoglutamic aciduria ORPHA:51208	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	INHBC
Fowler vasculopaty ORPHA:221126	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	PTAFR
Transcobalamin deficiency ORPHA:859	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	CCL2
Frontorhiny ORPHA:391474	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	GAPDHS
Fructose-1,6-bisphosphatase deficiency ORPHA:348	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	PTAFR
Fuhrmann syndrome ORPHA:2854	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	NUAK2
Triglyceride deposit cardiomyovasculopathy ORPHA:565612	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	TICAM1
GCGR-related hyperglucagonemia ORPHA:438274	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	INHBC
Tritanopia ORPHA:88629	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	GAPDHS
Tuberculosis ORPHA:3389	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	PTAFR
GNE myopathy ORPHA:602	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	CFB
Galactosialidosis ORPHA:351	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	TICAM1
Typical urticaria pigmentosa ORPHA:158766	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	GPM6B
Tyrosinemia type 3 ORPHA:69723	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	INHBC
Gaucher disease type 2 ORPHA:77260	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	TICAM1
Gaucher disease type 3 ORPHA:77261	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	TICAM1
Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome ORPHA:2072	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	TICAM1
Urocanic aciduria ORPHA:210128	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	INHBC
Vein of Galen aneurysmal malformation ORPHA:1053	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	ID1
Vibratory urticaria ORPHA:493342	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	PTAFR
Glaucoma secondary to spherophakia/ectopia lentis and megalocornea ORPHA:238763	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	THBS1
Glutamate-cysteine ligase deficiency ORPHA:33574	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	CFB
X-linked Charcot-Marie-Tooth disease type 1 ORPHA:101075	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	SERPINA3
Graham Little-Piccardi-Lassueur syndrome ORPHA:505	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	CCL4
X-linked central congenital hypothyroidism with late-onset testicular enlargement ORPHA:329235	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	UNC13A
X-linked dominant chondrodysplasia, Chassaing-Lacombe type ORPHA:163966	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	L3MBTL1
X-linked epilepsy-learning disabilities-behavior disorders syndrome ORPHA:85294	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	UNC13A
Gyrate atrophy of choroid and retina ORPHA:414	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	SDC4
X-linked hyper-IgM syndrome ORPHA:101088	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	LTB
X-linked intellectual disability, Stocco Dos Santos type ORPHA:85288	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	CX3CL1
Hawkinsinuria ORPHA:2118	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	INHBC
X-linked lymphoproliferative disease due to SH2D1A deficiency ORPHA:538931	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	LTB
X-linked mendelian susceptibility to mycobacterial diseases due to CYBB deficiency ORPHA:319623	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	PTAFR
X-linked progressive cerebellar ataxia ORPHA:1175	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	SERPINA3
Hemolytic anemia due to red cell pyruvate kinase deficiency ORPHA:766	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	INHBC
Hemorrhagic disease due to alpha-1-antitrypsin Pittsburgh mutation ORPHA:178396	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	PTAFR
X-linked severe congenital neutropenia ORPHA:86788	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	LTB
X-linked thrombocytopenia with normal platelets ORPHA:852	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	LTB
Hereditary angioedema type 1 ORPHA:100050	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	MAFB
Hereditary angioedema type 2 ORPHA:100051	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	MAFB
Xanthinuria type I ORPHA:93601	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	CFB
Xanthinuria type II ORPHA:93602	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	SDC4
Xq21 microdeletion syndrome ORPHA:1435	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	GPM6B
Hereditary hypophosphatemic rickets with hypercalciuria ORPHA:157215	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	FSCN2
Hereditary thrombophilia due to congenital antithrombin deficiency ORPHA:82	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	INHBC
Hermansky-Pudlak syndrome type 8 ORPHA:231537	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	DEDD2
High myopia-sensorineural deafness syndrome ORPHA:363396	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	BDKRB2
Histidinemia ORPHA:2157	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	PTAFR
Huntington disease-like 2 ORPHA:98934	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	UNC13A
Hyaluronidase deficiency ORPHA:67041	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	CFB
Hydroxykynureninuria ORPHA:79155	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	SOD2
Hyper-IgM syndrome type 2 ORPHA:101089	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	CCL22
Hyperammonemia due to N-acetylglutamate synthase deficiency ORPHA:927	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	FKBPL
Hyperekplexia-epilepsy syndrome ORPHA:163985	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	GPM6B
Hyperinsulinism due to UCP2 deficiency ORPHA:276556	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	LTB
Hypertryptophanemia ORPHA:2224	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	CFB
Hyperzincemia and hypercalprotectinemia ORPHA:251523	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	LTB
Hypochondrogenesis ORPHA:93297	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	RASL11B
Hypochondroplasia ORPHA:429	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	ID1
Hypomyelination-congenital cataract syndrome ORPHA:85163	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	DNAJB4
Hypoplasminogenemia ORPHA:722	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	MASP2
IRIDA syndrome ORPHA:209981	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	INHBC
Idiopathic CD4 lymphocytopenia ORPHA:228000	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	DEDD2
Immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome ORPHA:37042	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	LTB
Immunodeficiency due to interleukin-1 receptor-associated kinase-4 deficiency ORPHA:70592	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	IRF1
Immunodeficiency with factor H anomaly ORPHA:200421	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	CFB
Infantile hypotonia-oculomotor anomalies-hyperkinetic movements-developmental delay syndrome ORPHA:522077	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	UNC13A
Infantile spasms-psychomotor retardation-progressive brain atrophy-basal ganglia disease syndrome ORPHA:263410	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	SCTR
Intellectual disability, Birk-Barel type ORPHA:166108	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	UNC13A
Interstitial lung disease due to SP-C deficiency ORPHA:440392	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	CX3CL1
Isolated bone marrow mastocytosis ORPHA:158778	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	GPM6B
Isolated focal cortical dysplasia type Ia ORPHA:268973	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	FKBPL
Isolated oxycephaly ORPHA:63440	1/101	0.5014126645233709	0.5312419675785659	0	0	1.4531617647058823	1.0031551089790296	GPM6B
Jervell and Lange-Nielsen syndrome ORPHA:90647	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	PTAFR
46,XY disorder of sex development due to testicular 17,20-desmolase deficiency ORPHA:443087	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	CFB
Acrodermatitis continua of Hallopeau ORPHA:163931	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	IL1A
Limbic encephalitis with LGI1 antibodies ORPHA:163908	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	CCL4
Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2) ORPHA:402020	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	ID1
Andersen-Tawil syndrome ORPHA:37553	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	SOD2
Angelman syndrome due to maternal 15q11q13 deletion ORPHA:98794	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	GPM6B
Marie Unna hereditary hypotrichosis ORPHA:444	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	BDKRB2
Mitochondrial myopathy with reversible cytochrome C oxidase deficiency ORPHA:254864	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	GAPDHS
Multiple epiphyseal dysplasia due to collagen 9 anomaly ORPHA:166002	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	GPM6B
Myelodysplastic syndrome ORPHA:52688	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	ID1
NON RARE IN EUROPE: Asperger syndrome ORPHA:1162	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	GPM6B
NON RARE IN EUROPE: Hyperlipoproteinemia type 4 ORPHA:413	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	INHBC
NON RARE IN EUROPE: Non-alcoholic fatty liver disease ORPHA:33271	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	INHBC
Neonatal severe primary hyperparathyroidism ORPHA:417	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	SCTR
Nephrogenic diabetes insipidus ORPHA:223	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	STAT5A
Benign familial neonatal epilepsy ORPHA:1949	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	UNC13A
Benign familial neonatal-infantile seizures ORPHA:140927	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	UNC13A
Occipital pachygyria and polymicrogyria ORPHA:280640	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	UNC13A
Brachydactyly type E ORPHA:93387	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	DKK1
Bradyopsia ORPHA:75374	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	NANOS1
Oculootodental syndrome ORPHA:99806	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	FKBPL
Bullous pemphigoid ORPHA:703	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	CCL4
CHARGE syndrome ORPHA:138	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	GPM6B
PEHO syndrome ORPHA:2836	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	UNC13A
Caudal regression sequence ORPHA:3027	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	FKBPL
Papillary renal cell carcinoma ORPHA:319298	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	SDC4
Cerebral sinovenous thrombosis ORPHA:329217	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	INHBC
Pediatric multiple sclerosis ORPHA:477738	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	CCL4
Classic mycosis fungoides ORPHA:2584	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	LTB
Coats plus syndrome ORPHA:313838	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	LTB
Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection ORPHA:431166	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	IRF1
Congenital amegakaryocytic thrombocytopenia ORPHA:3319	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	INHBC
Congenital bilateral absence of vas deferens ORPHA:48	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	SCTR
Proximal symphalangism ORPHA:3250	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	DKK1
Pustulosis palmaris et plantaris ORPHA:163927	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	IL1A
RELA fusion-positive ependymoma ORPHA:530792	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	TICAM1
Congenital short bowel syndrome ORPHA:2301	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	THBS1
Radio-ulnar synostosis-amegakaryocytic thrombocytopenia syndrome ORPHA:71289	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	ID1
Sezary syndrome ORPHA:3162	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	LTB
Dense deposit disease ORPHA:93571	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	CFB
Dermatofibrosarcoma protuberans ORPHA:31112	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	SDC4
Sarcoidosis ORPHA:797	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	CCL4
Ependymoma ORPHA:251636	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	TICAM1
FRAXE intellectual disability ORPHA:100973	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	GPM6B
Stevens-Johnson syndrome ORPHA:36426	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	LTB
Familial infantile myoclonic epilepsy ORPHA:352582	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	UNC13A
Familial porphyria cutanea tarda ORPHA:443062	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	S100A3
Fibrolamellar hepatocellular carcinoma ORPHA:401920	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	DNAJB1
Generalized pustular psoriasis ORPHA:247353	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	IL1A
Griscelli syndrome type 3 ORPHA:79478	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	PLK2
Hemochromatosis type 2 ORPHA:79230	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	TNFSF14
Hereditary chronic pancreatitis ORPHA:676	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	SCTR
Hereditary methemoglobinemia ORPHA:621	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	SDC4
Hereditary pulmonary alveolar proteinosis ORPHA:264675	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	PTAFR
Hyperostosis corticalis generalisata ORPHA:3416	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	ID1
Hypomyelination with atrophy of basal ganglia and cerebellum ORPHA:139441	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	GPM6B
Idiopathic ventricular fibrillation, non Brugada type ORPHA:228140	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	UNC13A
Immunoglobulin-mediated membranoproliferative glomerulonephritis ORPHA:329903	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	NCOA7
Infantile convulsions and choreoathetosis ORPHA:31709	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	UNC13A
Isolated congenitally uncorrected transposition of the great arteries ORPHA:216718	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	UNC13A
Isolated growth hormone deficiency type II ORPHA:231679	1/102	0.5048453145340125	0.5312419675785659	0	0	1.4387012230634828	0.9833568962561355	LTB
Keratosis follicularis spinulosa decalvans ORPHA:2340	1/103	0.508254502873238	0.5312419675785659	0	0	1.4245242214532872	0.9640794838440134	CFB
Alopecia-intellectual disability syndrome ORPHA:2850	1/103	0.508254502873238	0.5312419675785659	0	0	1.4245242214532872	0.9640794838440134	SERPINA3
Alveolar rhabdomyosarcoma ORPHA:99756	1/103	0.508254502873238	0.5312419675785659	0	0	1.4245242214532872	0.9640794838440134	GPM6B
Atypical juvenile parkinsonism ORPHA:391411	1/103	0.508254502873238	0.5312419675785659	0	0	1.4245242214532872	0.9640794838440134	UNC13A
Mutilating palmoplantar keratoderma with periorificial keratotic plaques ORPHA:659	1/103	0.508254502873238	0.5312419675785659	0	0	1.4245242214532872	0.9640794838440134	SDC4
NON RARE IN EUROPE: Barrett esophagus ORPHA:1232	1/103	0.508254502873238	0.5312419675785659	0	0	1.4245242214532872	0.9640794838440134	DNAJB4
NON RARE IN EUROPE: Celiac disease ORPHA:555	1/103	0.508254502873238	0.5312419675785659	0	0	1.4245242214532872	0.9640794838440134	CCL4
NON RARE IN EUROPE: Diabetes mellitus type 1 ORPHA:243377	1/103	0.508254502873238	0.5312419675785659	0	0	1.4245242214532872	0.9640794838440134	CCL4
NON RARE IN EUROPE: Tourette syndrome ORPHA:856	1/103	0.508254502873238	0.5312419675785659	0	0	1.4245242214532872	0.9640794838440134	GPM6B
NON RARE IN EUROPE: Ventricular septal defect ORPHA:1480	1/103	0.508254502873238	0.5312419675785659	0	0	1.4245242214532872	0.9640794838440134	CITED2
Pendred syndrome ORPHA:705	1/103	0.508254502873238	0.5312419675785659	0	0	1.4245242214532872	0.9640794838440134	CX3CL1
Chronic granulomatous disease ORPHA:379	1/103	0.508254502873238	0.5312419675785659	0	0	1.4245242214532872	0.9640794838440134	PTAFR
Congenital fibrosis of extraocular muscles ORPHA:45358	1/103	0.508254502873238	0.5312419675785659	0	0	1.4245242214532872	0.9640794838440134	UNC13A
Duane retraction syndrome ORPHA:233	1/103	0.508254502873238	0.5312419675785659	0	0	1.4245242214532872	0.9640794838440134	MAFB
Familial hyperphosphatemic tumoral calcinosis/Hyperphosphatemic hyperostosis syndrome ORPHA:306661	1/103	0.508254502873238	0.5312419675785659	0	0	1.4245242214532872	0.9640794838440134	PTAFR
Subcortical band heterotopia ORPHA:99796	1/103	0.508254502873238	0.5312419675785659	0	0	1.4245242214532872	0.9640794838440134	GPM6B
Female infertility due to oocyte meiotic arrest ORPHA:488191	1/103	0.508254502873238	0.5312419675785659	0	0	1.4245242214532872	0.9640794838440134	LTB
Hereditary diffuse gastric cancer ORPHA:26106	1/103	0.508254502873238	0.5312419675785659	0	0	1.4245242214532872	0.9640794838440134	SDC4
Zimmermann-Laband syndrome ORPHA:3473	1/103	0.508254502873238	0.5312419675785659	0	0	1.4245242214532872	0.9640794838440134	GPM6B
Idiopathic juvenile osteoporosis ORPHA:85193	1/103	0.508254502873238	0.5312419675785659	0	0	1.4245242214532872	0.9640794838440134	DKK1
Inherited congenital spastic tetraplegia ORPHA:210141	1/103	0.508254502873238	0.5312419675785659	0	0	1.4245242214532872	0.9640794838440134	GPM6B
Alternating hemiplegia of childhood ORPHA:2131	1/104	0.5116403887089291	0.5312419675785659	0	0	1.4106225014277556	0.9453050647082822	GPM6B
Aplasia cutis congenita ORPHA:1114	1/104	0.5116403887089291	0.5312419675785659	0	0	1.4106225014277556	0.9453050647082822	ID1
Autosomal dominant Emery-Dreifuss muscular dystrophy ORPHA:98853	1/104	0.5116403887089291	0.5312419675785659	0	0	1.4106225014277556	0.9453050647082822	THBS1
Autosomal dominant severe congenital neutropenia ORPHA:486	1/104	0.5116403887089291	0.5312419675785659	0	0	1.4106225014277556	0.9453050647082822	STX11
Autosomal recessive hypohidrotic ectodermal dysplasia ORPHA:248	1/104	0.5116403887089291	0.5312419675785659	0	0	1.4106225014277556	0.9453050647082822	IL23A
Autosomal recessive malignant osteopetrosis ORPHA:667	1/104	0.5116403887089291	0.5312419675785659	0	0	1.4106225014277556	0.9453050647082822	LTB
NON RARE IN EUROPE: Alzheimer disease ORPHA:238616	1/104	0.5116403887089291	0.5312419675785659	0	0	1.4106225014277556	0.9453050647082822	PTAFR
NON RARE IN EUROPE: Dementia with Lewy body ORPHA:1648	1/104	0.5116403887089291	0.5312419675785659	0	0	1.4106225014277556	0.9453050647082822	CAMK1G
NON RARE IN EUROPE: Hereditary essential tremor ORPHA:862	1/104	0.5116403887089291	0.5312419675785659	0	0	1.4106225014277556	0.9453050647082822	UNC13A
Narcolepsy type 2 ORPHA:83465	1/104	0.5116403887089291	0.5312419675785659	0	0	1.4106225014277556	0.9453050647082822	CCL4
Chronic myelomonocytic leukemia ORPHA:98823	1/104	0.5116403887089291	0.5312419675785659	0	0	1.4106225014277556	0.9453050647082822	ETS1
Primary myelofibrosis ORPHA:824	1/104	0.5116403887089291	0.5312419675785659	0	0	1.4106225014277556	0.9453050647082822	STX11
Congenital glaucoma ORPHA:98976	1/104	0.5116403887089291	0.5312419675785659	0	0	1.4106225014277556	0.9453050647082822	CYP1B1
Familial bicuspid aortic valve ORPHA:402075	1/104	0.5116403887089291	0.5312419675785659	0	0	1.4106225014277556	0.9453050647082822	ID1
Squamous cell carcinoma of the esophagus ORPHA:99977	1/104	0.5116403887089291	0.5312419675785659	0	0	1.4106225014277556	0.9453050647082822	IRF1
Familial or sporadic hemiplegic migraine ORPHA:569	1/104	0.5116403887089291	0.5312419675785659	0	0	1.4106225014277556	0.9453050647082822	GPM6B
Follicular lymphoma ORPHA:545	1/104	0.5116403887089291	0.5312419675785659	0	0	1.4106225014277556	0.9453050647082822	CCL4
Xeroderma pigmentosum-Cockayne syndrome complex ORPHA:220295	1/104	0.5116403887089291	0.5312419675785659	0	0	1.4106225014277556	0.9453050647082822	GAPDHS
Hereditary hemorrhagic telangiectasia ORPHA:774	1/104	0.5116403887089291	0.5312419675785659	0	0	1.4106225014277556	0.9453050647082822	CCL2
Inherited acute myeloid leukemia ORPHA:319465	1/104	0.5116403887089291	0.5312419675785659	0	0	1.4106225014277556	0.9453050647082822	MAFB
Autosomal agammaglobulinemia ORPHA:33110	1/105	0.5150031301416665	0.5312419675785659	0	0	1.3969881221719458	0.9270165917310036	LTB
Autosomal dominant progressive external ophthalmoplegia ORPHA:254892	1/105	0.5150031301416665	0.5312419675785659	0	0	1.3969881221719458	0.9270165917310036	GAPDHS
Multiple endocrine neoplasia type 1 ORPHA:652	1/105	0.5150031301416665	0.5312419675785659	0	0	1.3969881221719458	0.9270165917310036	TICAM1
Autosomal recessive Stickler syndrome ORPHA:250984	1/105	0.5150031301416665	0.5312419675785659	0	0	1.3969881221719458	0.9270165917310036	GPM6B
Benign familial infantile epilepsy ORPHA:306	1/105	0.5150031301416665	0.5312419675785659	0	0	1.3969881221719458	0.9270165917310036	UNC13A
Dravet syndrome ORPHA:33069	1/105	0.5150031301416665	0.5312419675785659	0	0	1.3969881221719458	0.9270165917310036	UNC13A
Dysequilibrium syndrome ORPHA:1766	1/105	0.5150031301416665	0.5312419675785659	0	0	1.3969881221719458	0.9270165917310036	GPM6B
Extraskeletal myxoid chondrosarcoma ORPHA:209916	1/105	0.5150031301416665	0.5312419675785659	0	0	1.3969881221719458	0.9270165917310036	NR4A3
Familial cerebral saccular aneurysm ORPHA:231160	1/105	0.5150031301416665	0.5312419675785659	0	0	1.3969881221719458	0.9270165917310036	CSF1
Usher syndrome type 2 ORPHA:231178	1/105	0.5150031301416665	0.5312419675785659	0	0	1.3969881221719458	0.9270165917310036	UNC13A
Granulomatosis with polyangiitis ORPHA:900	1/105	0.5150031301416665	0.5312419675785659	0	0	1.3969881221719458	0.9270165917310036	CCL4
Atrial septal defect, ostium secundum type ORPHA:99103	1/106	0.5183428842553988	0.5322893295716875	0	0	1.3836134453781512	0.9091977385922757	CITED2
NON RARE IN EUROPE: Heterozygous familial hypercholesterolemia ORPHA:406	1/106	0.5183428842553988	0.5322893295716875	0	0	1.3836134453781512	0.9091977385922757	CFB
Childhood absence epilepsy ORPHA:64280	1/106	0.5183428842553988	0.5322893295716875	0	0	1.3836134453781512	0.9091977385922757	UNC13A
Essential thrombocythemia ORPHA:3318	1/106	0.5183428842553988	0.5322893295716875	0	0	1.3836134453781512	0.9091977385922757	STX11
Lennox-Gastaut syndrome ORPHA:2382	1/107	0.5216598069580667	0.5333039990776665	0	0	1.3704911209766926	0.8918328635531109	GPM6B
Myoclonic-astatic epilepsy ORPHA:1942	1/107	0.5216598069580667	0.5333039990776665	0	0	1.3704911209766926	0.8918328635531109	GPM6B
Pilomyxoid astrocytoma ORPHA:251615	1/107	0.5216598069580667	0.5333039990776665	0	0	1.3704911209766926	0.8918328635531109	GPM6B
Semantic dementia ORPHA:100069	1/107	0.5216598069580667	0.5333039990776665	0	0	1.3704911209766926	0.8918328635531109	MAFB
MODY ORPHA:552	1/108	0.52495405329796	0.534880881892026	0	0	1.3576140736668498	0.8749069741445356	SCTR
Narcolepsy type 1 ORPHA:2073	1/108	0.52495405329796	0.534880881892026	0	0	1.3576140736668498	0.8749069741445356	CCL4
Generalized epilepsy with febrile seizures-plus ORPHA:36387	1/108	0.52495405329796	0.534880881892026	0	0	1.3576140736668498	0.8749069741445356	UNC13A
Malignant migrating focal seizures of infancy ORPHA:293181	1/109	0.5282257770666134	0.5352376236648427	0	0	1.3449754901960784	0.8584056957797925	UNC13A
Behavioral variant of frontotemporal dementia ORPHA:275864	1/109	0.5282257770666134	0.5352376236648427	0	0	1.3449754901960784	0.8584056957797925	SDC4
Congenital stationary night blindness ORPHA:215	1/109	0.5282257770666134	0.5352376236648427	0	0	1.3449754901960784	0.8584056957797925	L3MBTL1
Situs ambiguus ORPHA:157769	1/109	0.5282257770666134	0.5352376236648427	0	0	1.3449754901960784	0.8584056957797925	GPM6B
Situs inversus totalis ORPHA:101063	1/109	0.5282257770666134	0.5352376236648427	0	0	1.3449754901960784	0.8584056957797925	CITED2
Tetralogy of Fallot ORPHA:3303	1/112	0.5379073369162519	0.5444454371439633	0	0	1.3084260731319555	0.8113144073177951	CITED2
Acute promyelocytic leukemia ORPHA:520	1/113	0.5410904890151278	0.5470627902183853	0	0	1.2966780462184875	0.796379136895972	STAT5A
Male infertility with azoospermia or oligozoospermia due to single gene mutation ORPHA:399805	1/115	0.5473916355948805	0.552214469388668	0	0	1.2738003095975232	0.7675803001330718	NANOS1
Infantile spasms syndrome ORPHA:3451	1/115	0.5473916355948805	0.552214469388668	0	0	1.2738003095975232	0.7675803001330718	GPM6B
Early infantile epileptic encephalopathy ORPHA:1934	1/116	0.5505099247008397	0.5547492750560717	0	0	1.2626598465473147	0.7536946608064634	UNC13A
Normosmic congenital hypogonadotropic hypogonadism ORPHA:432	1/117	0.5536068857376767	0.5572570410282548	0	0	1.2517114604462474	0.7401375331167496	UNC13A
Kallmann syndrome ORPHA:478	1/120	0.5627712434419151	0.5658599988943954	0	0	1.2199703410776075	0.7013390513087742	GPM6B
X-linked non-syndromic intellectual disability ORPHA:777	1/132	0.5975981191383021	0.6002191635204875	0	0	1.107543780871127	0.570204287727377	GPM6B
Autosomal dominant non-syndromic intellectual disability ORPHA:178469	1/133	0.6003728767370318	0.6023456244152477	0	0	1.0990975935828877	0.5607643794366315	UNC13A
Amyotrophic lateral sclerosis ORPHA:803	1/137	0.6112832466409985	0.6126208467430576	0	0	1.0665549307958477	0.5249528425154502	UNC13A
Non-specific early-onset epileptic encephalopathy ORPHA:442835	1/138	0.6139643128765275	0.6146353121255729	0	0	1.058716187204809	0.5164613157678267	UNC13A
Retinitis pigmentosa ORPHA:791	1/174	0.6991726429357337	0.6991726429357337	0	0	0.8368752125127508	0.29948213968623344	FSCN2
